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Abstract 17 
Hippocampal pyramidal cells encode memory engrams which guide adaptive behavior. Selection of engram-18 
forming cells is regulated by somatostatin-positive dendrite-targeting interneurons, which inhibit pyramidal cells 19 
that are not required for memory-formation. Here, we found that GABAergic neurons of the mouse nucleus 20 
incertus (NI) selectively inhibit somatostatin-positive interneurons in the hippocampus, both mono-synaptically 21 
and indirectly via the inhibition of their sub-cortical excitatory inputs. We demonstrated that NI GABAergic 22 
neurons receive monosynaptic inputs from brain areas processing important environmental information, and 23 
their hippocampal projections are strongly activated by salient environmental inputs in vivo. Optogenetic 24 
manipulations of NI GABAergic neurons can shift hippocampal network state and bidirectionally modify the 25 
strength of contextual fear memory formation. Our results indicate that brainstem NI GABAergic cells are essential 26 
for controlling contextual memories. 27 
  28 
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Introduction 1 
Fear memories, which allow mice to avoid future aversive events, are formed by associating aversive stimuli 2 
(unconditioned stimulus, US) with their environmental context. The dorsal hippocampus (HIPP) plays an essential 3 
role in contextual memory encoding and transmits this information mainly via CA1 pyramidal neurons to the 4 
cortex (1–3). Dorsal CA1 pyramidal neurons receive the unified representation of the multisensory context at their 5 
proximal dendrites from the CA3 subfield inputs (4), while the discrete sensory attribute of the aversive stimulus 6 
(US) is primarily conveyed by the direct temporo-ammonic pathway to their distal dendrites (5–7). At the cellular 7 
level, the dendritic interactions of these inputs may result in long-term synaptic plasticity in CA1 pyramidal 8 
neurons (8–10), a subset of which can form memory engrams to encode contextual fear memories (11). Both 9 
intact contextual information processing and direct sensory information related inputs are required for precise 10 
episodic memory formation (12–14). 11 
The number of dorsal CA1 pyramidal neurons participating in the formation of a given memory engram 12 
component must be delicately balanced (15). The majority of pyramidal cells must be inhibited, (i.e., excluded 13 
from memory encoding at the moment of memory formation), because if the US information reaches too many 14 
pyramidal cells, engrams may lack specificity, which may engender memory interference (16, 17). Exclusion of US 15 
information in hippocampal CA1 is achieved by somatostatin (SOM) expressing oriens-lacunosum moleculare 16 
(OLM) inhibitory interneurons (16). OLM cells establish far the most abundant local SOM-positive synapses (16, 17 
18). OLM cells selectively inhibit the distal dendrites of CA1 pyramidal neurons, which receive the primary sensory-18 
related inputs from the entorhinal cortex, representing the US (19–22). Indeed, artificial silencing of dorsal CA1 19 
SOM-positive neurons at the moment of US presentation disrupts fear learning (16, 17). OLM cell activity is 20 
synchronized with the US via cholinergic and glutamatergic excitatory inputs from the medial septum (MS) and 21 
diagonal bands of Broca. Cholinergic neurons are rapidly and reliably recruited by salient environmental stimuli 22 
(16, 23) and strongly innervate hippocampal OLM neurons (3, 16, 21), while MS glutamatergic neurons display 23 
locomotion-related activity increases, and also innervate hippocampal OLM cells (22, 24).  24 
Conversely, if too many pyramidal neurons are inhibited, allocation to engrams may be insufficient and 25 
memory formation would be impaired (25). Thus, to balance the sparsity of hippocampal engrams, activation of 26 
OLM neurons must be adequately controlled. Inhibitory regulation of OLM neurons would ideally arise also from 27 
an extra-hippocampal area that integrates relevant environmental information, yet the source of such balancing 28 
inhibitory input to OLM neurons was, until now, unknown. 29 
The pontine nucleus incertus (NI), characterized by expression of the neuropeptide, relaxin-3 (26–28), sends 30 
an ascending GABAergic pathway to the septo-hippocampal system. NI neurons display activity related to 31 
hippocampal theta rhythm and are thought to play an important role in stress and arousal (29–34).  32 
Here, using cell type-specific neuronal tract-tracing, immunogold receptor localization and 33 
electrophysiological methods, we discovered that NI GABAergic neurons selectively inhibit hippocampal SOM-34 
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positive neurons both mono-synaptically and also indirectly via inhibition of excitatory glutamatergic and 1 
cholinergic neurons in the MS. Using monosynaptic rabies-tracing, we observed that NI receives direct inputs from 2 
several brain areas that process salient environmental stimuli, and indeed, using in vivo two-photon calcium 3 
imaging in head-fixed awake mice, we demonstrated that such stimuli rapidly activated hippocampal fibers of NI 4 
GABAergic neurons. Behavioral conditioned fear experiments revealed that optogenetic stimulation of NI 5 
GABAergic cells or their fibers in the dorsal HIPP, precisely at the moment of US presentation, prevented the 6 
formation of contextual fear memories. In parallel, optogenetic stimulation of NI GABAergic neurons decreased 7 
the power and frequency of the encoding-related hippocampal theta rhythm in vivo. In contrast, optogenetic 8 
inhibition of NI GABAergic neurons during fear conditioning, resulted in the formation of excessively enhanced 9 
contextual memories. These findings demonstrate the fundamental importance of NI GABAergic neurons in 10 
hippocampus-dependent episodic memory formation. 11 
 12 
Results 13 
 14 
NI GABAergic neurons selectively inhibit hippocampal SOM-positive interneurons 15 
We injected Cre-dependent adeno-associated tracer virus (AAV5, see Supplementary Materials and 16 
Methods) into the NI of vesicular GABA transporter (vGAT)-Cre mice to reveal the projections of GABAergic 17 
neurons of NI (Fig. 1A). It demonstrated that NI GABAergic fibers selectively project to the stratum oriens of the 18 
HIPP and the hilus of the dentate gyrus (Fig. 1B). SOM neurons are typically found only in these sub-regions of 19 
HIPP (35). GABAergic NI nerve terminals were all positive for the neuropeptide, relaxin-3 (Fig. 1C). Double 20 
retrograde tracing in wild-type (WT) mice, using the retrograde tracers FluoroGold (FG) and Choleratoxin B (CTB), 21 
revealed that NI and HIPP are connected almost exclusively ipsilaterally (Fig. S1A-C). Using Cre-dependent AAV5 22 
viral tracing, we also confirmed that brainstem areas surrounding NI do not send GABAergic projections to the 23 
HIPP (Fig. S2A-F) and NI GABAergic neurons do not use glutamate, glycine, acetylcholine, serotonin or other 24 
monoamines as neurotransmitters (Fig. S2G-J). 25 
To identify the targets of NI GABAergic fibers in the HIPP, we injected Cre-dependent AAV5 tracer virus into 26 
the NI of vGAT-Cre-tdTomato reporter mice (Supplementary Materials and Methods and Fig. S1D). Double 27 
immunoperoxidase reactions and correlated light- and electron microscopy revealed that NI fibers establish 28 
synaptic contacts with tdTomato-expressing GABAergic interneurons in the HIPP (at least 87% were identified as 29 
interneurons, Fig. S1E). Then, using Cre-dependent AAV5 viral-labeling of SOM interneurons in SOM-Cre mice, we 30 
found that most of the relaxin-3 positive NI terminals (at least 62%) targeted SOM-positive cells (Fig. 1D-E). The 31 
vast majority of SOM-positive CA1 fibers are present in stratum lacunosum-moleculare, which clearly indicated 32 
that they originate from OLM cells as described before (16, 18, 36). Using Cre-dependent AAV5 viral-labeling in 33 
vGAT-Cre mice, we observed that NI GABAergic fibers establish symmetrical synapses typically with SOM-positive 34 
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interneurons (Fig. 1F-H) that also contain the previously identified markers (37) metabotropic glutamate receptor 1 
1α (mGluR1α) and parvalbumin (PV, Fig. S1F-H). These results demonstrate that the primary target of NI fibers in 2 
the HIPP are the dendrite-targeting SOM-positive interneurons, the local effect of which neurons mostly originate 3 
from OLM cells. Using a combination of CTB and Cre-dependent AAV5 in vGAT-Cre mice, we observed that some 4 
SOM positive GABAergic interneurons in the HIPP, which project to the subiculum or the MS (38, 39) also receive 5 
contacts from the NI (Supplementary Materials and Methods and Fig. S1I-P). 6 
Using correlated light- and immuno-electron microscopic analysis, we found that the synapses of NI fibers 7 
are symmetrical, contain GABAA-receptor γ2 subunits and the GABAergic synapse specific scaffolding protein 8 
gephyrin, postsynaptically in the HIPP (Fig. 1I). 9 
To investigate the functional properties of these GABAergic synapses, we injected channelrhodopsin (ChR2) 10 
containing Cre-dependent AAV5 into the NI of vGAT-Cre mice and 6-12 weeks later, we cut horizontal slices from 11 
the HIPP for in vitro optogenetic experiments (Fig. 1J, Supplementary Materials and Methods, Fig. S3A, Fig. S4A). 12 
Light stimulation of hippocampal NI GABAergic fibers reliably evoked gabazine-sensitive inhibitory postsynaptic 13 
potentials (IPSCs) from voltage-clamped interneurons located to the stratum oriens of CA1 (Fig. 1K-N, Fig. S3B-C), 14 
indicating GABAA-receptor-dependent GABAergic neurotransmission in these synapses. Although NI GABAergic 15 
neurons express relaxin-3 and HIPP SOM neurons express its receptor (28, 40), gabazine could block all currents 16 
at these time scales. Recorded neurons were filled with biocytin and post-hoc neurochemical analysis of filled 17 
neurons revealed that at least 12 of 18 cells were clearly SOM-positive (Fig. 1K). Although not all recorded neurons 18 
could be fully morphologically reconstructed, 6 of them were unequivocally identified as typical dendrite-targeting 19 
OLM neurons (Fig. 1M). Altogether we found, that 14 out of 18 randomly recorded and NI GABAergic cells targeted 20 
neurons were either SOM-positive or SOM-false-negative OLM cells, suggesting that at least 78% of the target 21 
cells are SOM-positive. Whereas, in immunohistochemistry described above, this number was at least 62%. 22 
Because only 14% of CA1 interneurons are SOM-positive (41), these numbers suggest a very high target specificity 23 
for SOM-containing interneurons. Light stimulation suggested that NI GABAergic synapses display short-term 24 
synaptic depression at higher stimulation frequencies (30-50 Hz: Fig. S3C) that was not observed at lower 25 
frequencies (5-20 Hz: Fig. S3C). These data clearly demonstrate that NI fibers directly target SOM positive 26 
dendrite-targeting OLM interneurons in the HIPP with functional GABAergic synapses. 27 
 28 
NI GABAergic neurons inhibit MS neurons that excite OLM interneurons 29 
HIPP SOM neurons receive their main extra-hippocampal excitatory inputs from glutamatergic and 30 
cholinergic neurons of the MS (16, 21, 22). We hypothesized that NI may also inhibit HIPP SOM-positive OLM cells 31 
indirectly, by inhibition of these excitatory input neurons in the MS.  32 
Using Cre-dependent AAVs to label GABAergic NI neurons in vGAT-Cre mice (Fig. 2A), we determined that 33 
MS is strongly innervated by relaxin-3 positive NI GABAergic fibers (Fig. 2B-C). NI neurons established GABAA-34 
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receptor γ2 subunit-positive and gephyrin-positive symmetrical synapses in MS (Fig. 2D). Using Cre-dependent 1 
AAV5 viral tracing we also confirmed that brainstem areas surrounding NI do not send GABAergic projections to 2 
the MS (Fig. S2A-H). 3 
To investigate, whether GABAergic NI fibers target the glutamatergic or cholinergic cells in the MS, we 4 
injected Cre-dependent AAV5 into the NI of vesicular glutamate transporter 2 (vGluT2)-Cre (Fig. 2E) or choline 5 
acetyltransferase (ChAT)-Cre (Fig. 2G) mice. These experiments revealed that relaxin-3 positive terminals of the 6 
NI frequently establish gephyrin-positive synapses on glutamatergic (at least 55%, Fig. 2F) and cholinergic (at least 7 
8%, Fig. 2H) cells in the MS, indicating that NI projections can also inhibit the main extra-hippocampal excitatory 8 
input to hippocampal OLM cells.  9 
In addition, we performed double retrograde tracing by injecting FG into the MS and CTB into the HIPP of 10 
WT mice bilaterally (Fig. 2I-J). We observed that many (at least 37%) of the individual NI GABAergic neurons that 11 
target HIPP also send axon collaterals to the MS (Fig. 2K). These data indicate that NI GABAergic neurons can 12 
synchronously inhibit HIPP OLM cells both directly in HIPP, and also indirectly by inhibition of their excitatory 13 
afferents in the MS. 14 
 15 
NI GABAergic fibers in HIPP are rapidly activated by salient environmental stimuli in vivo 16 
These anatomical and in vitro physiological data indicated that NI GABAergic neurons would be ideal to 17 
counterbalance the MS activation of OLM cells, which would permit fine-tuned regulation of pyramidal cell 18 
participation in memory formation. To test, whether NI GABAergic neurons indeed respond to sensory stimuli and 19 
behavioral state, we combined two-photon (2P) calcium imaging with behavioral monitoring in awake mice. We 20 
injected AAV2/1-EF1a-DIO-GCaMP6f into the NI of vGAT-Cre mice and implanted a chronic imaging window 21 
superficial to the dorsal CA1 of the HIPP (Fig. 3A). After recovery, water restriction and habituation to head-22 
restraint, we engaged mice in two different behavioral paradigms, while imaging the fluorescent activity of 23 
GCaMP6f-positive NI boutons in the stratum oriens of the dorsal CA1 (Fig. 3B-C). 24 
In the first experiment, the random foraging task, mice ran on a cue-less burlap belt in search of water 25 
rewards, which were delivered at 3 random locations on each lap. Bouton fluorescence was elevated during 26 
periods of running (Fig. 3D), consistent with previous observations of increased neural activity in the NI during 27 
hippocampal theta rhythm (32). To investigate how calcium dynamics in NI GABAergic axon terminals are 28 
modulated by locomotion state transitions, we examined GCaMP6f fluorescence changes in NI-GABAergic 29 
boutons in relation to the onset and offset of locomotion. We calculated peri-event time histograms (PETHs) 30 
aligned to running-start and running-stop events (Fig. 3E) and found that the majority of dynamic NI boutons were 31 
similarly modulated by the onset and offset of running (Fig. 3H). 32 
In the second behavioral paradigm, the salience task, we explored whether discrete stimuli of various 33 
sensory modalities also modulate the activity of NI GABAergic axonal boutons in the HIPP, while the mouse was 34 
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stationary (16, 42). The movements of mice were restrained while different sensory cues (aversive air-puffs, water 1 
rewards, auditory tones and light flashes) were randomly presented to them (Fig. 3B, F). We calculated peri-2 
stimulus time histograms (PSTHs) and observed calcium responses in NI boutons to all types of stimuli. Salient 3 
stimuli with special valence such as aversive air-puff and water reward had particularly strong effects on bouton 4 
calcium dynamics (Fig. 3F), and also activated a larger fraction of NI boutons (Fig. 3I).  5 
Finally, to determine the stimulus-dependent variability of the responses of NI terminals in the HIPP, we 6 
analyzed the Jaccard similarity of boutons in the salience experiments, based on their stimulus preference. 7 
Although all stimuli recruited an overlapping population of boutons, we detected some differences between the 8 
activated bouton populations (Fig. 3J). 9 
 10 
NI GABAergic neurons receive monosynaptic inputs from areas processing salient environmental stimuli 11 
Above mentioned data demonstrate that NI GABAergic neurons transmit information on salient 12 
environmental modalities from the brainstem to the HIPP. To directly identify upstream brain areas containing 13 
neurons that synaptically target the GABAergic neurons of NI, we used mono-trans-synaptic rabies tracing (43). 14 
We used Cre-dependent helper viruses and G-protein deleted rabies virus in vGAT-Cre mice (Supplementary 15 
Materials and Methods, Fig. 4A). These studies assessed the level of convergence onto NI GABAergic neurons, and 16 
thus the type of inputs that can fine-tune HIPP memory formation via the modulation of NI GABAergic cells. The 17 
specificity of the virus expression was tested in WT mice (Fig. 4B). 18 
We detected an extensive convergence of inputs onto NI GABAergic neurons, with prominent synaptic 19 
inputs from several brain areas highly relevant to associated behaviors, including the prefrontal cortex, lateral 20 
habenula, zona incerta, mammillary areas, and raphe regions. These afferent regions play essential roles in 21 
movement, aversive or rewarding stimulus processing, and memory encoding (Fig. 4C, for details see Table S6). 22 
We did not find rabies labeled neurons in the HIPP, confirming the lack of direct output from HIPP to NI. 23 
Rabies labeling revealed that NI GABAergic neurons are targeted by the lateral habenula (LHb; Fig. 4C), 24 
which plays a fundamental role in aversive behavior (44, 45). To confirm that the glutamatergic neurons of the 25 
LHb target the NI, we injected Cre-dependent AAV5 into the LHb of vGluT2-Cre mice (Fig. 4D-E) and detected 26 
strong fiber labeling in NI (Fig. 4F). 27 
Rabies tracing also revealed that NI GABAergic neurons receive a strong monosynaptic input from the 28 
median raphe region (MRR, Fig. 4C, Table S6). HIPP memory formation is sensitive to stress, and NI neurons 29 
express functional corticotrophin-releasing hormone (CRH) receptor 1 that plays a role in stress processing (32, 30 
46). MRR contains a small CRH-positive cell population (47). Injection of Cre-dependent AAV5 into the MRR of 31 
CRH-Cre mice (Fig. 4G-H) revealed that MRR is a prominent source of CRH signaling in the NI (Fig. 4I). 32 
MS cholinergic neurons are known to transmit a rapid and precisely timed attention signal to cortical areas 33 
(23), while the activity of MS glutamatergic (vGluT2-positive) neurons is correlated with movement and HIPP theta 34 
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rhythm (22, 24). We observed that virtually none of the NI projecting rabies-labeled MS neurons were positive for 1 
ChAT, parvalbumin or calbindin (Table S7). Injections of Cre-dependent AAV5 into the MS of ChAT-Cre mice 2 
confirmed the lack of cholinergic innervation of NI from MS. 3 
Because vGluT2 is not detectable in neuronal cell bodies, we directly labeled MS vGluT2 positive 4 
glutamatergic cells, using injections of Cre-dependent AAV5 into the MS of vGluT2-Cre mice (Fig. 4J-K) and 5 
observed that MS glutamatergic neurons provide a strong input into the NI (Fig. 4L). 6 
 7 
NI GABAergic cells regulate hippocampal network activity 8 
HIPP theta activity is essential for contextual memory formation (25, 48) and typical during exploration (49, 9 
50), therefore, we investigated the effects of NI GABAergic neurons on HIPP theta activity. We injected ChR2-10 
containing Cre-dependent AAV5 into the NI of vGAT-Cre mice. Later, we implanted an optic fiber over the NI (Fig. 11 
S4A) and placed a multichannel linear probe into the dorsal HIPP (Fig. 5A-D). After recovery and habituation, HIPP 12 
rhythmic activities were recorded in an open field or on a linear track, where mice could behave freely (Fig. 5B). 13 
Blue light stimulation was triggered by the experimenter during every recording condition, while 14 
electrophysiological activity in HIPP was continuously recorded. 15 
As revealed by wavelet analysis of the HIPP local field potentials (LFP), stimulation of NI GABAergic neurons 16 
significantly decreased the power of HIPP theta activity (Fig. 5E-G, Fig. S5A-D), while no such effect occurred after 17 
introduction of light into a dummy fiber implanted in the same mice (Supplementary Materials and Methods, Fig. 18 
5E-G, Fig. S5C-D). The effect was most prominent in the high theta range (8-12Hz), less in the low theta range (5-19 
8Hz), while it was generally stronger when mice actively explored their environment (Fig. 5G). Stimulation of NI 20 
GABAergic neurons also reduced HIPP theta power during REM sleep (Fig. S5D-E). Current source density analysis 21 
revealed a prominent effect on the magnitude of apical dendritic sinks and sources, excluding the possibility of 22 
general silencing of CA1, instead implying a stimulus-triggered alteration of excitation – inhibition balance (Fig. 23 
S5F-I). Importantly, none of these effects were observed when we stimulated the NI GABAergic neurons in 24 
urethane-anaesthetized mice. 25 
 26 
NI GABAergic neurons bi-directionally regulate hippocampus-dependent contextual memory formation 27 
Our findings above indicated that NI GABAergic neurons can integrate behavioral modalities from several 28 
key brain areas and are activated by salient environmental inputs, while they inhibit HIPP OLM cells both directly 29 
and indirectly. These findings suggest that this brainstem projection is ideally suited to provide the sub-cortical 30 
inhibition of these HIPP SOM-positive dendrite-targeting neurons for balancing the selection of HIPP pyramidal 31 
cells that participate in memory formation. 32 
To test this possibility, first we injected ChR2-containing Cre-dependent AAV5 (ChR2-mice) or control Cre-33 
dependent AAV5 (CTRL-mice) into the NI of vGAT-Cre mice and implanted an optic fiber over the NI (Fig. 6A, Fig. 34 
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S4A). After handling, mice were placed into a new multisensory context (environment “A”), where they received 1 
four foot-shocks and light stimulation of NI precisely aligned to foot-shocks (Supplementary Materials and 2 
Methods, Fig. 6A). All mice displayed equally strong immediate reactions to foot-shocks. 24 h later, mice were 3 
placed into the same environment “A”, where CTRL-mice displayed strong freezing behavior as expected, while 4 
ChR2-mice displayed almost no freezing behavior (Fig. 6A). An elevated plus-maze test, 1 hour later, revealed 5 
significantly lower anxiety levels in ChR2-mice compared to CTRL-mice (Fig. 6A). These findings indicated that 6 
contextual fear memory formation can be severely impaired or blocked if NI GABAergic neurons are strongly 7 
activated precisely at the time of US presentation.  8 
In an additional control experiment, we conducted the same contextual fear conditioning experiment with 9 
the same cohorts of ChR2- and CTRL-mice one week later, in a different environment “B” (Fig. S6A) without light 10 
stimulations. On the second day of the experiment, both ChR2- and CTRL-mice displayed high freezing behavior 11 
(Fig. S6A-B), confirming that ChR2-mice could also display appropriate fear behavior.  12 
To confirm that NI GABAergic cells act directly on HIPP SOM-positive cells, we created a second cohort of 13 
ChR2- and CTRL-mice as described above (Fig. 6B). However here, optic fibers were implanted bilaterally above 14 
the dorsal HIPP (Fig. 6B, Fig. S4A-B). In similar contextual fear conditioning experiments described above, ChR2-15 
mice again displayed significantly lower freezing levels in environment “A”, where they received NI light 16 
stimulation during foot-shocks, than in environment “B”, where NI was not stimulated (Fig. 6B). This effect was 17 
absent in CTRL mice (Fig. 6B). These results suggest that dorsal HIPP fibers of NI GABAergic neurons can inhibit 18 
the formation of contextual memory directly in the HIPP. 19 
The balancing of the selection of pyramidal cells that associate US with environmental context should be 20 
timed precisely during US presentation. To test the importance of timing, we injected ChR2-containing Cre-21 
dependent AAV5 into the NI of vGAT-Cre mice and implanted an optic fiber over the NI (Fig. 6C, Fig. S4A). Mice 22 
were divided into two groups: one group received NI GABAergic neuron stimulation aligned to foot-shocks as 23 
described above (“light-aligned-mice”), while a second group received light stimulation exactly between foot-24 
shocks (i.e. 15 seconds after each foot-shock, “light-shifted-mice”, Fig. 6C). “Light-shifted-mice” displayed 25 
significantly higher freezing levels compared to “light-aligned-mice”, indicating that activation of NI GABAergic 26 
neurons needs to occur precisely during US presentation to be effective (Fig. 6C). 27 
Finally, we investigated whether inhibition of NI GABAergic neurons during contextual fear conditioning 28 
induced opposite effects, i.e. whether it can create inadequately strong fear. We injected archaerhodopsinT-3 29 
(ArchT 3.0)-containing Cre-dependent AAV5 (ArchT-mice) or control Cre-dependent AAV5 (CTRL-mice) into the NI 30 
of vGAT-Cre mice and implanted an optic fiber over the NI (Fig. 6D, Fig. S3D and Fig. S4A). After handling, mice 31 
were tested in a delay cued fear conditioning paradigm. First, we placed mice into environment “A”, where they 32 
received three auditory tones, at the end of which mice received foot-shocks. NI received a constant yellow light 33 
during the experiments. 24 h later, mice were placed back into environment “A” to test their hippocampus-34 
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dependent contextual fear memories. We observed that ArchT-mice displayed significantly stronger freezing 1 
behavior than CTRL-mice (Fig. 6D). The auditory cue dependent fear component of established fear memories is 2 
known to be hippocampus-independent (51). Therefore, on the next day, we placed these mice into a different 3 
neutral environment “B” and presented them with the auditory cues (Fig. 6D). At this time, however, we found 4 
no difference between the freezing levels of the two groups, further suggesting that the effect of NI GABAergic 5 
neurons on contextual memory formation was hippocampus-dependent. 6 
   7 
Discussion 8 
Encoding of episodic memories is essential for the survival of animals. HIPP pyramidal neurons of the dorsal 9 
CA1 region play a key role in this process (1, 25, 52), by pairing multisensory contextual information with direct 10 
sensory-related inputs (e.g. an US) at the cellular level, via long-term synaptic plasticity mechanisms (8, 10, 15). 11 
However, if too many pyramidal neurons receive the same direct sensory-related inputs, information pairing is 12 
not specific enough and the memory trace will be lost (16). Therefore, only a subpopulation of pyramidal neurons 13 
participate in this process by forming cell-assemblies that encode memory engrams (11, 15), while the direct 14 
sensory-related input must be excluded from most of the pyramidal neurons (16). 15 
HIPP SOM-positive OLM neurons selectively inhibit the distal dendrites of pyramidal neurons to filter out 16 
direct sensory-related excitatory inputs from the entorhinal cortex (3, 16, 22). Upon salient environmental stimuli, 17 
OLM cells are activated by glutamatergic and cholinergic inputs from the MS (3, 16, 19–22), therefore dendrite-18 
targeting OLM cells can efficiently block direct sensory-related inputs to most pyramidal cells at the time of 19 
memory formation, thereby leaving only a subpopulation of pyramidal neurons to form engrams.  20 
However, the selection of these pyramidal neurons must be precisely balanced. We hypothesized that 21 
dorsal CA1 dendrite-targeting OLM interneurons should also be precisely inhibited in time based on sub-cortical 22 
information, because otherwise, under-recruitment of pyramidal neurons will lead to unstable engrams (17, 25, 23 
52). We discovered that NI GABAergic neurons are well suited to counter-balance the activation of OLM cells in a 24 
time- and sensory stimulus-dependent manner.  25 
We demonstrated that NI GABAergic neurons receive monosynaptic inputs from several brain areas that 26 
process salient environmental stimuli and that they are activated rapidly by such stimuli in vivo. We revealed that 27 
these NI GABAergic neurons provide a selective, direct inhibition of HIPP SOM-positive interneurons, the vast 28 
majority of which CA1 fibers originate from dendrite-targeting OLM interneurons (16, 18). Although other types 29 
of HIPP neurons have little contribution to the local SOM-positive innervation of the CA1 area, some SOM-positive 30 
bistratified interneurons may also support the inhibition of pyramidal cell dendrites, in addition to extra-31 
hippocampal projecting GABAergic neurons, the rare local collaterals of which also target pyramidal cell dendrites 32 
(53). 33 
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MS cholinergic cells release GABA, immediately followed by a strong cholinergic excitatory component (54), 1 
which results in an effective net activation of OLM cells (16). Here we revealed that medial septal glutamatergic 2 
and cholinergic excitatory inputs to OLM neurons are also inhibited by NI GABAergic neurons simultaneously, 3 
which facilitates the effective and precisely timed inhibition of hippocampal OLM cells. We also demonstrated 4 
that many of these direct and indirect inhibitory actions are provided by collaterals of the same NI GABAergic 5 
neurons, further facilitating a highly synchronous inhibition.  6 
Although OLM cells in intermediate and ventral HIPP seem to regulate memory formation differently (17), 7 
previous studies agree that direct inhibition of dorsal CA1 OLM neurons resulted in weaker memory formation 8 
(16, 17). Indeed, we found that dorsal CA1 OLM neurons can be inhibited by activating brainstem NI GABAergic 9 
neurons. Our behavioral data revealed that the precisely-timed activation of NI GABAergic neurons could lead to 10 
an almost complete inhibition of the formation of contextual fear memories. 11 
 In contrast, NI-lesioned rats display pathologically strong memory formation, indicated by impaired fear 12 
extinction and increased fear generalization (55, 56). In this regard, we also observed stronger contextual fear 13 
memory formation after inhibition of GABAergic NI neurons. 14 
We described that NI GABAergic neurons receive monosynaptic inputs from several brain areas that process 15 
salient environmental stimuli and our analysis of our 2P calcium imaging data revealed that different 16 
environmental inputs activated different fractions of NI fibers. Emotionally more salient inputs were more 17 
effective. Furthermore, our Jaccard similarity analysis suggested that NI fibers may be activated by different 18 
sensory stimuli. Previous studies have also shown heterogeneity amongst the NI cells based on their activity 19 
patterns or based on their CRH receptor / relaxin-3 content (30, 32). Therefore, one may speculate that different 20 
subset of NI GABAergic neurons could enforce the disinhibition of a different subset of pyramidal neurons, leading 21 
to the selection of different sets of memory-encoding pyramidal cell populations, which would be beneficial to 22 
encode different contextual memories more specifically.  23 
The activity of medial septal glutamatergic neurons is positively correlated with the running speed of the 24 
animal and with the frequency of hippocampal theta rhythm (22, 24, 57). NI neurons also display firing phase-25 
locked to hippocampal theta (32, 58, 59). Our results reveal that MS glutamatergic neurons innervate the NI, and 26 
that the activity of NI GABAergic fibers is elevated during running, active exploration and new episodic memory 27 
formation. Therefore, MS glutamatergic neurons may support the phase-locking of NI GABAergic neurons to HIPP 28 
theta rhythm. 29 
We observed that activation of NI GABAergic neurons partly inhibited and reorganized HIPP theta rhythmic 30 
activity, which rhythm is known to be essential for episodic memory formation (25), further suggesting a role of 31 
NI GABAergic neurons in memory formation. This effect on theta activity may be facilitated by one of the different 32 
populations of septo-hippocampal parvalbumin-positive GABAergic neurons (60–63). Although it is unclear, which 33 
one of them receives GABAergic synapses from NI, some of them express metabotropic relaxin-3 receptors and 34 
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may be inhibited by NI (64, 65). Different types of MS parvalbumin cells target different HIPP interneurons in a 1 
rhythmic fashion and they mostly target HIPP basket cells that are known to be fundamental in modulating HIPP 2 
theta rhythms (63, 66–68). 3 
In the rat, NI GABAergic neurons that express CRH-R1 are activated by different stressors (29, 32, 33, 56). 4 
Our results demonstrate that NI GABAergic neurons receive inputs from several brain areas, some of them related 5 
to stress regulation, and amongst which, the projection from CRH-expressing neurons of the median raphe region, 6 
was previously unknown. Therefore, CRH-dependent activation of NI GABAergic neurons might contribute to 7 
impaired episodic memory formation observed under stressful conditions (46, 69). 8 
Pathological neurodegeneration of NI GABAergic neurons may result in hyperthymesia-like symptoms, in 9 
which the unnecessarily encoded detailed memories of everyday life cause cognitive problems in patients (70, 10 
71). NI GABAergic neuron dysfunction may also contribute to general anxiety-like syndromes or post-traumatic 11 
stress disorders, where pathologically strong episodic memory formation is present. On the other hand, over-12 
activity of NI GABAergic neurons may lead to dementia-like disorders. 13 
An important physiological role of NI GABAergic neurons may be the fine-tuning of the selection of memory-14 
encoding pyramidal cells, based on the relevance and/or modality of environmental inputs. NI GABAergic neurons 15 
may also help filter out non-relevant everyday experiences, to which animals have already accommodated, by 16 
regulating the population sparsity of memory-encoding dorsal CA1 pyramidal neurons. Our data represent an 17 
unexpectedly specific role of an ascending inhibitory pathway from a brainstem nucleus in memory encoding. 18 
 19 
Methods Summary 20 
 21 
Ethical considerations and used mouse strains 22 
All experiments were performed in accordance with the Institutional Ethical Codex and the Hungarian Act 23 
of Animal Care and Experimentation guidelines (40/2013, II.14), which are in concert with the European 24 
Communities Council Directive of September 22, 2010 (2010/63/EU). All two-photon (2P) imaging experiments 25 
were conducted in accordance with the United States of America, National Institutes of Health guidelines and with 26 
the approval of the Columbia University Institutional Animal Care and Use Committee. The following mouse strains 27 
were used in the experiments: C57Bl/6J wild type, ChAT-iRES-Cre, CRH-iRES-Cre, vGAT-iRES-Cre, vGAT-iRES-28 
Cre::Gt(ROSA26)Sor-CAG/tdTomato, vGluT2-iRES-Cre (72), GlyT2-iRES-Cre and SOM-iRES-Cre. We used at least 6 29 
weeks-old mice from both genders in our experiments. 30 
 31 
Stereotaxic surgeries for viral gene transfer and retrograde tracing 32 
Mice were deeply anesthetized and were then mounted and microinjected using a stereotaxic frame. We 33 
used one of the following viruses: AAV2/1-EF1a-DIO-GCaMP6f; AAV2/5-EF1α-DIO-eYFP; AAV2/5-EF1α-DIO-34 
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mCherry; AAV2/5-CAG-FLEX-ArchT-GFP; AAV2/5-EF1α-DIO-hChR2(H134R)-eYFP. For retrograde tracing 1 
experiments we injected 2% FluoroGold or 0.5% Cholera toxin B subunit into the target areas. The coordinates for 2 
the injections were defined by a stereotaxic atlas (73). 3 
 4 
Hippocampal cranial window implants for two-photon imaging experiments 5 
We implanted an imaging window/head-post as described previously (16). Briefly, under anesthesia, a 3-6 
mm diameter craniotomy was made in the exposed skull over the left dorsal hippocampus and the underlying 7 
cortex was slowly aspirated. A custom-made sterilized cylindrical steel imaging cannula with a glass cover slip 8 
window (3-mm diameter × 1.5-mm height, as described in (42)) was inserted into the craniotomy and was 9 
cemented to the skull. Analgesia was administered during and after the procedure for three days. 10 
 11 
Optic fiber implantations for behavioral experiments 12 
For behavioral experiments, optic fibers were implanted into the brain. Their positions are illustrated in Fig. 13 
S4A-B. After the surgeries, mice received meloxicam analgesia, and were placed into separate cages until 14 
experiments or perfusions. 15 
 16 
Stereotaxic surgeries for electrophysiological recordings in freely moving mice 17 
AAV2/5-EF1a-DIO-hChR2(H134R)-YFP transfected vGAT-IRES-Cre male mice received optical fibers above 18 
their nucleus incertus and a multichannel (16 or 32) linear type silicon probe into the dorsal hippocampus. 19 
Stainless steel wires above the cerebellum served as reference for the electrophysiological recordings. An 20 
additional optical fiber with the tip in the dental acrylate above the skull was used for control illumination sessions. 21 
Analgesia was administered during and after the procedures.  22 
 23 
Mono-trans-synaptic rabies tracing 24 
We used the monosynaptic rabies tracing technique published by Wickersham et al. (43). Briefly, C57Bl/6 25 
and vGAT-Cre mice were prepared for stereotaxic surgeries as described above, and 30 nl of the 1:1 mixture of 26 
the following viruses was injected into the NI: AAV2/8-hSyn-FLEX-TVA-p2A-eGFP-p2A-oG and AAV2/5-CAG-FLEX-27 
oG. These viruses contain an upgraded version of the rabies glycoprotein (oG) that has increased trans-synaptic 28 
labeling potential (74). After 2-3 weeks of survival, mice were injected with the genetically modified Rabies(ΔG)-29 
EnvA-mCherry at the same coordinates. After 10 days of survival, mice were prepared for perfusions. 30 
 31 
Antibodies and perfusions 32 
The list and specifications of the primary and secondary antibodies used can be found in Supplementary 33 
Table 1-3. Combinations of the used primary and secondary antibodies in the different experiments are listed in 34 
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Supplementary Table 4-5. Mice were anesthetized and perfused transcardially with 0.1M phosphate-buffered 1 
saline solution for 2 min followed by 4% freshly depolymerized paraformaldehyde solution; or with artificial 2 
cerebrospinal fluid (ACSF) for 2 min. After perfusion, brains were removed from the skull, and were immersion-3 
fixed in 4% PFA with or without 0.2% glutaraldehyde (GA) for 2 h. Brains were cut into 50 or 60 μm sections using 4 
a vibrating microtome. 5 
 6 
Fluorescent immunohistochemistry and laser-scanning confocal microscopy 7 
Perfusion-fixed sections were washed in 0.1 M phosphate buffer (PB) and then incubated in a mixture of 8 
primary antibodies for 48-72 h. This was followed by extensive washes in tris buffered saline (TBS), and incubation 9 
in the mixture of appropriate secondary antibodies overnight. For visualizing cell layers in the hippocampus, 10 
nuclear counterstaining was done on forebrain sections using Draq5 according to the manufacturer`s protocol. 11 
Following this, sections were washed in TBS and PB, dried on slides and covered with Aquamount (BDH Chemicals 12 
Ltd) or with Fluoromount-G Mounting Medium (Invitrogen). Sections were evaluated using a Nikon A1R confocal 13 
laser-scanning microscope system built on a Ti-E inverted microscope operated by NIS-Elements AR 4.3 software. 14 
Regions of interests were reconstructed in z-stacks. In case of the monosynaptic rabies tracing experiments, 15 
coronal sections were prepared from the whole brain for confocal laser-scanning microscopy, and labeled cells 16 
were scanned using a Nikon Ni-E C2+ confocal system.  17 
 18 
Immunogold-immunoperoxidase double labeling and electron microscopy 19 
For synaptic detection of GABAA-receptor γ2 subunit, sections were pepsin-treated mildly and were blocked 20 
in 1% HSA in TBS, followed by incubation in a mixture of primary antibodies. After washes in TBS, sections were 21 
incubated in blocking solution and in mixtures of secondary antibody solutions overnight. After washes in TBS, the 22 
sections were treated with 2% glutaraldehyde. The immunoperoxidase reaction was developed using 3-3′-23 
diaminobenzidine as chromogen. Immunogold particles were silver-enhanced. The sections were contrasted using 24 
osmium tetroxide solution, dehydrated and embedded in Durcupan. 70-100 nm serial sections were prepared 25 
using an ultramicrotome and documented in electron microscope. 26 
 27 
Silver-gold intensified and nickel-intensified immunoperoxidase double labeling (SI-DAB/DAB-Ni) 28 
Perfusions, sectioning and incubations of sections in primary antibody solutions were performed as 29 
described above. The SI-DAB reaction was followed by subsequent washes and incubation in secondary antibody 30 
solutions. Labeling was developed using ammonium nickel sulphate-intensified 3-3’-diaminobenzidine (DAB-Ni) 31 
and intensified with silver-gold (SI/DAB) as described in detail in Dobó et al. (75). After washes in TBS, sections 32 
were blocked in 1% HSA and incubated in primary antibody solutions for the second DAB-Ni reaction. This was 33 
followed by incubation with ImmPRESS secondary antibody solutions overnight. The second immunoperoxidase 34 
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reaction was developed by DAB-Ni, resulting in a homogenous deposit, which was clearly distinguishable from the 1 
silver-gold intensified SI-DAB at the electron microscopic level (75). Further dehydration, contrasting and 2 
processing of the sections for electron microscopy was performed as described above. 3 
 4 
In vitro slice preparation 5 
In all slice studies, brains were removed and placed into an ice-cold cutting solution, which had been 6 
bubbled with 95% O2/5% CO2 (carbogen gas) for at least 30 min before use. Then 300-450 µm horizontal slices of 7 
ventral hippocampi or 300 µm coronal brainstem slices containing the nucleus incertus were cut using a vibrating 8 
microtome. After acute slice preparation, slices were placed in an interface-type holding chamber for recovery 9 
(76). This chamber contained standard artificial cerebrospinal fluid (ACSF) at 35°C that was gradually cooled to 10 
room temperature, and saturated with carbogen gas. 11 
 12 
Intracellular recordings 13 
To record GABAergic currents, membrane potential was clamped far (~0 mV) from GABA reversal potential. 14 
In case of intracellular recordings, fast glutamatergic transmission was blocked by adding the α-amino-3-hydroxy-15 
5-methyl-4-isoxazolepropionic acid (AMPA)-receptor antagonist NBQX and the N-methyl-D-aspartate (NMDA)-16 
receptor antagonist AP-5 to the recording solution. To test GABAA-receptor dependent synaptic transmission, we 17 
administered the GABAA-receptor antagonist gabazine into the ACSF. All drugs were administered from stock 18 
solutions via pipettes into the ACSF containing superfusion system. For ChR2 illumination, we used a blue laser 19 
diode attached to a single optic fiber positioned above the hippocampal slice. For ArchT illumination, we used a 20 
red laser diode with optic fiber positioned above NI. Cells recorded in current clamp configuration were 21 
depolarized above firing threshold to test the effectivity of ArchT mediated inhibition on action potential 22 
generation. 23 
 24 
In vivo two-photon calcium imaging 25 
Calcium imaging in head-fixed, behaving mice was performed using a two-photon microscope equipped 26 
with an 8 kHZ resonant scanner and a Ti:Sapphire laser tuned to 920 nm. For image acquisition we used a Nikon 27 
40× NIR Apo water-immersion objective (0.8 NA, 3.5 mm WD) coupled to a piezo-electric crystal. Fluorescent 28 
signals were collected by a GaAsP photomultiplier tube.  29 
 30 
Behavior for two-photon calcium imaging 31 
For the in vivo head-fixed 2P calcium-imaging experiments, behavioral training of the mice was started three 32 
days after implantation surgery. Mice were hand habituated, water restricted (>90 % of their pre-deprivation body 33 
weight) and trained for 5-7 days to run on a 2 m-long cue-less burlap belt on a treadmill for water rewards, while 34 
15 
 
being head-fixed. Mice were also habituated to the 2P setup and the scanner and shutter sounds prior to the 1 
actual 2P imaging experiments. The treadmill was equipped with a lick-port for water delivery and lick detection. 2 
Locomotion was recorded by tracking the rotation of the treadmill wheel using an optical rotary encoder. Stimulus 3 
presentation and behavioral read-out were driven by microcontroller systems, using custom made electronics. 4 
During random foraging experiments three water rewards were presented per lap in random locations, while mice 5 
were running on a cue-less burlap belt. In salience experiments, discrete stimuli were presented as described (42), 6 
with slight modifications. Stimuli were repeated 10× for each modality in a pseudorandom order during one 7 
experiment. The acquired 2P imaging data were pre-processed for further analysis using the SIMA software 8 
package (77). Motion correction and extraction of dynamic GCaMP6f fluorescent signals were conducted as 9 
described (78). Regions of interest (ROIs) were drawn manually over the time-averages of motion corrected time-10 
series to isolate the bouton calcium signals of GCaMP6f-expressing axons.  11 
 12 
Optogenetics and contextual fear conditioning (CFC) 13 
After optic fiber implantations, mice received 5 days of handling. On the 6th day, mice were placed into the 14 
first environmental context (environment “A”) in a plexiglass shock chamber, where they received 4 foot-shocks. 15 
Optogenetic stimulation was precisely aligned with the shocks, starting 2 seconds before shock onset and finishing 16 
2 seconds after shock offset. For the “ChR2-shifted” group, this laser stimulation was shifted by 15 seconds after 17 
shock onset. On the 7th day, mice were placed back into the first environment for 3 minutes to record freezing 18 
behavior. This was followed by 5 days of extensive handling to achieve full fear extinction that reset freezing 19 
behavior to a normal baseline. On the 13th day, mice were placed into the second environmental context 20 
(environment “B”), composed of another set of cues. Baseline freezing levels were recorded for 3 minutes, 21 
followed by 4 shocks without optogenetic stimulation. 24 h later, freezing behavior was recorded in the second 22 
environment for 3 minutes. The behavior of the mice was recorded and freezing behavior was analyzed manually. 23 
Freezing behavior was recorded when mice displayed only respiration-related movements for at least 2 seconds. 24 
 25 
Optogenetics and delay cued fear conditioning (CuedFC) 26 
After optic fiber implantations, mice received 5 days of handling. On the 6th day, mice were placed into the 27 
first environmental context (environment “A”) in a plexiglass shocking chamber, where they received 3 shocks 28 
paired with an auditory cue. The footshocks and the auditory cues were co-terminated each time. During the 29 
experiment, lasting 6 minutes, mice received a continuous yellow laser light illumination. On the 7th day, mice 30 
were placed back into the first environment for 3 minutes to record freezing behavior related to the contextual 31 
fear memories. 24 h later, on the 8th day, mice were placed into a second environmental context (environment 32 
“B”). Here, mice were presented with the auditory cue for 1 minute to record freezing behavior related to the 33 
cued fear memories.  34 
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Elevated plus maze (EPM) after optogenetic CFC 1 
One hour after freezing behavior assessment in the first environment (7th day) we placed the mice into an 2 
EPM to test their anxiety levels. The cross-shaped EPM apparatus consisted of two open arms with no walls and 3 
two closed arms and was on a pedestal 50 cm above floor level (Fig. 6A). The behavior of the mice was recorded 4 
camcorder and evaluated using an automated system (Noldus Ethovision 10.0; Noldus Interactive Technologies). 5 
Behavior was measured as total time in the open and closed arms. 6 
 7 
In vivo electrophysiological recordings in freely behaving mice 8 
Electrophysiological recordings commenced 7-day after surgery and habituation to connections to the 9 
head-stage. The signal from the silicon probe was multiplexed and sampled at 20 kHz. The movement of the mouse 10 
was tracked by a marker-based, high speed 4-camera motion capture system and reconstructed in 3D. After home 11 
cage recording, mice were placed into an open arena and into a linear track. Recordings were repeated 1-7 days 12 
later. In each recording situation, blue light stimulation was triggered manually by the experimenter. Mice were 13 
recorded in 3 - 9 sessions for 2 - 5 weeks. Then mice were processed for histological verification of the viral 14 
transduction zone and implantation. The analysis was performed in MATLAB environment by custom-written 15 
functions and scripts. Time-frequency decomposition of pyramidal LFP with continuous wavelet transform (79) 16 
and subsequent bias correction of spectral power (80) was used to calculate instant power. 17 
 18 
Data and code availability  19 
Data generated and analysed during the current study are presented in the manuscript or in the 20 
Supplementary Materials file, while additional datasets and custom written codes for in vivo electrophysiological 21 
recordings, 2P-imaging and data analysis are available from the following links: 22 
https://figshare.com/s/9fb345fc23ac2ac94fcd and https://figshare.com/s/5b0c6be2431caf10272b 23 
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Figure 1: NI neurons target HIPP SOM-positive neurons with GABAergic synapses 1 
 2 
  3 
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A: AAV2/5-EF1α-DIO-eYFP or AAV2/5-EF1α-DIO-mCherry was injected into the NI of vGAT-Cre mice (n=7). B: Images illustrate 1 
an injection site (upper panel) and the layer-specific distribution pattern of GABAergic NI fibers in the hippocampus (HIPP) 2 
stratum oriens and hilus (lower panel) where SOM neurons are known to be abundant. Scale bars: 200 μm. C: NI fibers (green) 3 
in the HIPP are immunopositive for relaxin-3 (red) and vGAT (white). Scale bar: 10 μm. (Also see Suppl. Data for Fig. 1). D: 4 
AAV2/5-EF1α-DIO-eYFP was injected into the bilateral hippocampus of SOM-Cre mice (n=2). E: Relaxin-3 positive NI fibers 5 
(red) establish synaptic contacts, marked by gephyrin (white), on SOM-positive interneurons (green) in the HIPP. Scale bar: 6 
10 μm. (Also see Suppl. Data for Fig. 1). F: eYFP-positive NI GABAergic fibers (green) in the HIPP establishing putative contacts 7 
(white arrowheads) with SOM-positive interneurons (red). Scale bar: 20 μm. G: NI GABAergic fiber (labeled with brown silver-8 
gold-intensified-DAB precipitate) establish synaptic contact with a SOM-positive interneuron (labeled with black DAB-Ni 9 
precipitate) in the stratum oriens of dorsal CA1. Black arrowhead indicates the NI nerve terminal shown in panel G. Scale bar: 10 
10 μm. H: The same terminal marked in F establishing a symmetrical synaptic contact (black arrow) on the soma (s) of the 11 
SOM-positive interneuron. Scale bar: 600 nm. I: EM images of serial sections of AAV-eYFP positive NI terminals 12 
(immunperoxidase labeling, black DAB precipitate) that establish symmetrical synaptic contacts in the CA1 stratum oriens or 13 
in the hilus (DG), containing the GABAA-receptor γ2 subunit (upper row) and the scaffolding protein gephyrin (lower row). 14 
The immunogold particles labeling the postsynaptic proteins are marked by black arrowheads. Scale bar: 300 nm. (See Suppl. 15 
Data for Fig. 1). J: For in vitro recordings AAV2/5-EF1α-DIO-ChR2-eYFP was injected into the NI of vGAT-Cre mice (n=9). After 16 
6 weeks, 300-μm-thick horizontal slices were prepared from the HIPP and transferred into a dual superfusion chamber. 17 
Interneurons located in the stratum oriens were whole-cell patch clamped in voltage clamp mode, and inhibitory postsynaptic 18 
currents (IPSCs) evoked by the optogenetic stimulation of NI GABAergic fibers were measured. (See Supplementary Materials 19 
and Methods and Suppl. Data for Fig. 1). K: A representative recorded cell (biocytin labeling, red) identified as a SOM-positive 20 
interneuron (white). Note the eYFP-positive NI GABAergic fibers (green) with putative contacts targets this neuron 21 
(arrowheads). Scale bar: 30 μm. L: Optogenetically evoked GABAergic IPSCs of interneuron in panel K. 100 consecutive traces 22 
evoked by 2 ms light pulses are overlaid with grey in every conditions. Responses are strong in controls (average in red), but 23 
that were completely abolished by 5 µM gabazine (average in blue), and partially recovered after 15 min of washout (average 24 
in orange). Scale bars: 10 ms, 40 pA. M: Morphological reconstruction of the OLM cell shown in K. Scale bar: 50 μm. N: PSC 25 
amplitude distribution from all 18 recorded neurons. Identified O-LM cells are filled black dots. (See Suppl. Data for Fig. 1).  26 
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Figure 2: NI GABAergic neurons innervate excitatory medial septal neurons and HIPP simultaneously 1 
  2 
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A: AAV2/5-EF1α-DIO-eYFP or AAV2/5-EF1α-DIO-mCherry was injected into the NI of vGAT-Cre mice (n=7). 1 
B: NI GABAergic fibers strongly innervate the medial septum (MS). Scale bar: 200 μm. 2 
C: NI GABAergic fibers in the MS (green) are immunopositive for relaxin-3 (red) and vGAT (white), indicated by white 3 
arrowheads. Scale bar: 10 μm. (For statistical data see Suppl. Data for Fig. 2). 4 
D: EM images of serial sections of relaxin-3 positive NI terminals (immunperoxidase labeling, black DAB precipitate) reveal 5 
the presence of symmetrical synapses in the MS, containing the GABAA-receptor γ2 subunit (upper row) or the scaffolding 6 
protein gephyrin (lower row). The immunogold particles labeling the postsynaptic proteins are marked by black 7 
arrowheads. Scale bar: 300 nm. (Suppl. Data for Fig. 2). 8 
E: AAV2/5-EF1α-DIO-eYFP was injected into the NI of vGluT2-Cre mice (n=2). 9 
F: vGluT2-positive neurons (green) are frequently innervated by relaxin-3 positive fibers (red), establishing gephyrin-positive 10 
(white) synaptic contacts (white arrowheads) on their dendrites. Scale bar: 10 μm. (See Suppl. Data for Fig. 2). G: AAV2/5-11 
EF1α-DIO-eYFP was injected into the NI of ChAT-Cre mice (n=2). 12 
H: ChAT-positive neurons (green) were innervated by relaxin-3 positive fibers (red), establishing gephyrin-positive (white) 13 
synaptic contacts (white arrowhead) on their dendrites. Scale bar: 10 μm. (See Suppl. Data for Fig. 2). 14 
I: Double retrograde tracing using FG in the MS and CTB in the bilateral hippocampi, respectively, in wild-type mice (n=3). 15 
J: Representative injection sites revealing green FG labeling in the MS and red CTB labeling in the hippocampus, respectively. 16 
The border of the MS and the hippocampal layers are labeled with white dashed lines. Scale bars: 500 μm. 17 
K: Dual projecting neurons containing FG labeling (green) and CTB labeling (red) were frequently detected in the NI, the 18 
majority of which were relaxin-3 positive (white neurons, indicated by white arrowheads). Although retrograde tracers cannot 19 
fill the entire HIPP or MS, at least 50/135 HIPP-projecting neurons also projected to the MS, and the majority of these neurons 20 
(at least 34/50) was positive for relaxin-3. Scale bar: 50 μm. 21 
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Figure 3: NI fibers are activated by relevant sensory stimuli in vivo 1 
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A: Experimental design of the in vivo 2P calcium-imaging experiments. AAV2/1-EF1a-DIO-GCaMP6f was injected into the NI 1 
of vGAT-Cre mice (n=5). After recovery, a cranial window implant was placed over the HIPP, and 2P imaging was performed. 2 
The inset on the right illustrates a representative virus injection site in the NI. Scale bar: 200 μm. 3 
B: Schematic of 2P imaging and behavioral apparatus. Mice were head-fixed under a 2P microscope on a linear treadmill and 4 
permitted to move freely during random foraging experiments. During salience experiments, mice were immobilized and 5 
randomly presented with sensory stimuli (water, airpuffs, auditory tone, and light). 6 
C: Left: laser scanning confocal microscopic image of GCaMP6f expressing fibers (green) along with cell nuclei (blue) in the 7 
dorsal CA1 region of the HIPP. Scale bar: 100 µm. CC: corpus callosum, SO: stratum oriens, SP: stratum pyramidale. Right: 2P 8 
field of view of GCaMP6f expressing NI GABAergic axons in hippocampal CA1. Exemplary fibers with regions of interest 9 
(colored polygons around axonal boutons) are enlarged on the right. Scale bar: 20 m. 10 
D: A representative random foraging experiment. Left: Fluorescence calcium signal in NI GABAergic axonal boutons; right: 11 
animal velocity. E: Running event-triggered signal averages during random foraging experiments (grand mean of ROIs + 99% 12 
CI, for ROIs with significant responses to each event, bootstrap test, n=3 mice). 13 
F: Signal averages triggered by delivery of sensory stimuli during movement-restrained salience experiments (grand mean of 14 
ROIs + 99% CI, for ROIs with significant responses to each stimulus, bootstrap test, n=3 mice). 15 
G: Average fluorescence during stationary and running periods differed significantly. We measured 54 responsive boutons 16 
(***: p<0.001, Wilcoxon signed-rank test). H: Fraction of ROIs responsive to the onset and offset of running. Dashed line 17 
indicates the 0.05 chance level of the PETH bootstrap test. There was no statistically significant difference between the two 18 
data groups (n.s.: non-significant, p>0.05, Z-test). I: Fraction of ROIs responsive to sensory stimuli. Dashed line indicates the 19 
0.05 chance level of the PSTH bootstrap test. Light stimuli recruited significantly fewer boutons than licking and air-puff, and 20 
auditory tones also recruited a smaller fraction of boutons compared to air-puff (*: p < 0.05, **: p <0.01 ***: p<0.001, Z-test 21 
between groups, Bonferroni-corrected p-value). 22 
J: Measure of overlap between the set of ROIs with significant responses to each stimulus (Jaccard similarity values indicated 23 
in red boxes). Differences among the fractions of responding ROIs depending on different stimuli was tested using 24 
permutation test (p-values indicated in grayscale-colored boxes). 25 
26 
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Figure 4: NI receives monosynaptic input from brain areas processing salient environmental stimuli 1 
 2 
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A: A cocktail of helper viruses (AAV2/8-hSyn-FLEX-TpEp(oG) + AAV2/5-CAG-FLEX-oG in a ratio 1:1) was injected into the NI of 1 
vGAT-Cre (n=3) or C57Bl/6 WT (n=2) mice, followed by an injection of RabiesΔG(EnvA)-mCherry 2 weeks later. 2 
B: Representative injection sites show the lack of virus expression in WT mice, while there is a strong helper (green) and 3 
rabies (red) virus expression present in the NI of vGAT-Cre mice. Inset illustrates some starter neurons expressing both 4 
viruses, indicated by white arrowheads. Scale bar for large images: 200 µm. Scale bar for inset: 20 µm. 5 
C: Confocal images illustrate neurons in different brain areas that establish synapses on NI GABAergic neurons. (For 6 
abbreviations see Suppl. Data for Fig. 4). 7 
D: AAV2/5-EF1α-DIO-mCherry was injected into the LHb of vGluT2-Cre mice (n=2). 8 
E: A representative injection site reveals mCherry-expression in the vGluT2-positive neurons of the bilateral LHb. Visualized 9 
in green for better visibility. Scale bar: 200 µm. 10 
F: Fibers of LHb vGluT2-positive cells heavily innervate NI. Scale bar: 100 µm.  11 
G: AAV2/5-EF1α-DIO-mCherry was injected into the MRR of CRH-Cre mice (n=3). 12 
H: A representative injection site illustrates mCherry-expression in the CRH-positive neurons of the MRR. Visualized in 13 
green for better visibility. Scale bar: 200 µm. 14 
I: Fibers of MRR CRH-positive neurons heavily innervate NI. Scale bar: 100 µm. 15 
J: AAV2/5-EF1α-DIO-eYFP was injected into the MS of vGluT2-Cre mice (n=2). 16 
K: A representative injection site reveals eYFP-expression in the vGluT2-positive neurons of the MS. 17 
Scale bar: 200 µm. 18 
L: Fibers of MS vGluT2-positive neurons heavily innervate NI. Scale bar: 100 µm.   19 
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Figure 5: NI regulates HIPP network activity 1 
 2 
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A: Experimental design of optogenetic in vivo experiments in freely-moving mice. AAV2/5-EF1α-DIO-ChR2-eYFP was injected 1 
into the NI of vGAT-Cre mice (n=5), and an optic fiber was implanted over the NI, with a linear probe implanted into the dorsal 2 
CA1. 3 
B: Five (5) days later, mice were placed into an open field, and their behavior was monitored under freely-moving conditions. 4 
NI was stimulated with blue laser pulses, and concurrent hippocampal network activity was recorded. 5 
C: A representative injection site illustrating AAV2/5-EF1a-DIO-ChR2-eYFP (ChR2) expression (green) and the position of the 6 
implanted optic fiber (blue) in the NI of a vGAT-Cre mouse. Scale bar: 500 µm. 7 
D: A representative coronal section from the dorsal HIPP CA1 and dentate gyrus (DG) regions illustrating the location of the 8 
linear probe. Scale bars: 500 µm. 9 
E: Theta power was reduced by optogenetic stimulation of NI GABAergic cells in ChR2-expressing mice, as revealed by the 10 
time-frequency decomposition of pyramidal LFP with continuous wavelet transform. Frequency range of 1-20 Hz is shown, 11 
for expanded scale, see Fig. S5C. Averages of all NI GABAergic neurons (left) and control (right) stimulation sessions in one 12 
representative mouse during running are shown. Boundaries of the stimulation periods are marked with white dashed lines. 13 
F: Separate analysis of NI stimulation on low theta (5-8 Hz, yellow graph) and high theta (8-12 Hz, orange graph) band power 14 
with concurrent speed (grey graph). NI GABAergic cell stimulation was controlled manually, while mice were running on a 15 
linear track, and tests started when mice started to demonstrate active exploratory behaviour. NI stimulation strongly 16 
reduced high theta band power and also moderately reduced low theta band power, independently from the speed of the 17 
animal (left). This effect was absent in control stimulations (left). The mean of all stimulation sessions in 4 mice are shown.  18 
G: High (top) and low (bottom) theta power during quiet (speed < 4 cm/s) and movement (speed > 4 cm/s) periods of 19 
stimulation sessions. Theta power during 4s stimulation versus 4s pre- and post-stimulation segments was compared. 20 
Medians and interquartile ranges are shown. The instant power values were averaged per stimulation sessions. Statistical 21 
difference between the segments was tested by two-sided Wilcoxon signed-rank test (*: p<0.05, **: p<0.01, ***: p<0.001).  22 
27 
 
Figure 6: NI regulates the establishment of contextual fear memories 1 
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A: Experimental design of contextual fear conditioning experiments with optogenetic stimulation of NI GABAergic neurons. 1 
ChR2 expressing mice spent significantly less time freezing in the environment ”A” and significantly more time in the open 2 
arm of the elevated plus maze than CTRL mice. Confocal image represents one of the injection sites to label NI GABAergic 3 
neurons and the blue area represents the position of the optic fiber. Scale bar: 200 µm. Medians and interquartile ranges are 4 
shown on the graphs. (For statistical details see Suppl. Data for Fig. 6). 5 
B: Experimental design of contextual fear conditioning experiments with light stimulation of NI GABAergic fibers in the 6 
bilateral HIPP. Illustration of the two sets of experiments in environment “A” and “B” with and without light stimulation of 7 
the HIPP fibers of NI GABAergic neurons. Pairwise comparison reveals that ChR2 expressing mice displayed significantly more 8 
freezing in environment ”B”, where they received no light stimulation, than in environment ”A”. This was not observed in 9 
CTRL mice. Insets illustrate a representative injection site and optic fiber localization; white arrowheads mark NI GABAergic 10 
fibers in the HIPP stratum oriens. Scale bars: 200 µm. Data from individual mice are shown in the graphs. (For statistical details 11 
see Suppl. Data for Fig. 6). 12 
C: Experimental design of contextual fear conditioning experiments with optogenetic stimulation of NI GABAergic neurons 13 
“aligned” to or 15 seconds “shifted” after foot-shocks. “Light-aligned” mice displayed significantly less freezing than “Light-14 
shifted” mice, demonstrating the importance of timing. The inset illustrates a representative injection site and optic fiber 15 
localization. Scale bar: 200 µm. Medians and interquartile ranges are shown on the graphs. (For statistical details see Suppl. 16 
Data for Fig. 6). 17 
D: Experimental design of delayed cued fear conditioning experiments with optogenetic inhibition of NI GABAergic neurons. 18 
Light inhibition of NI GABAergic neurons caused significantly stronger contextual freezing behavior in ArchT-mice in 19 
environment ”A” compared to CTRL mice. However, there was no difference in HIPP-independent cued fear freezing levels 20 
between the two groups in environment ”B”. The inset illustrates a representative injection site and optic fiber localization. 21 
Scale bar: 200 µm. Medians and interquartile ranges are shown on the graphs. (For statistical details see Suppl. Data for Fig. 22 
6). 23 
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Supplementary Materials and Methods 
 
Ethical considerations 
All experiments were performed in accordance with the Institutional Ethical Codex 
and the Hungarian Act of Animal Care and Experimentation guidelines (40/2013, II.14), 
which are in concert with the European Communities Council Directive of September 22, 
2010 (2010/63/EU). The Animal Care and Experimentation Committee of the Institute of 
Experimental Medicine of Hungarian Academy of Sciences and the Animal Health and 
Food Control Station, Budapest, have also approved the experiments under the project 
number PE/EA/2553-6/2016. All two-photon (2P) imaging experiments were conducted 
in accordance with the United States of America, National Institutes of Health guidelines 
and with the approval of the Columbia University Institutional Animal Care and Use 
Committee. 
 
Mice 
The following mouse strains were used in the experiments: C57Bl/6J wild type, 
ChAT-iRES-Cre, CRH-iRES-Cre, vGAT-iRES-Cre, vGAT-iRES-Cre::Gt(ROSA26)Sor-
CAG/tdTomato (all strains from The Jackson Laboratory), vGluT2-iRES-Cre (received 
from Dr Sébastien Arthaud) (71), GlyT2-iRES-Cre (courtesy of Prof Hanns Ulrich 
Zeilhofer) and SOM-iRES-Cre (courtesy of Prof Josh Huang). We used adult (at least 6 
weeks-old) mice from both genders in our experiments. Mice had ad libitum access to 
food and water. Mice were housed in a vivarium (3-5 mice/cage) until used in 
experiments. Mice used for 2P-experiments were maintained on a reversed 12h light-dark 
cycle, with experiments performed during the dark phase of the cycle. Mice used for all 
other experiments were maintained on a normal 12h light-dark cycle, with experiments 
performed during the light phase of the cycle. 
 
Stereotaxic surgeries for viral gene transfer and retrograde tracing 
Mice were anesthetized with 2% isoflurane followed by an intraperitoneal injection 
of an anesthetic mixture (containing 8.3 mg/ml ketamine and 1.7 mg/ml xylazine-
hydrochloride in 0.9% saline, 10 ml/kg body weight); and were then mounted in a small 
animal stereotaxic frame (David Kopf Instruments, CA, USA) and the skull surface was 
exposed. A Nanoject II precision microinjector pump (Drummond, Broomall, PA) was 
used for the microinjections. For 2P-microscopic, anterograde tracing and optogenetic 
experiments 10-100 nl of one of the following viruses were injected into the target brain 
areas: AAV2/1-EF1a-DIO-GCaMP6f (courtesy of Dr Thomas Reardon); AAV2/5-EF1α-
DIO-eYFP; AAV2/5-EF1α-DIO-mCherry; AAV2/5-CAG-FLEX-ArchT-GFP (UNC 
Vector Core); AAV2/5-EF1α-DIO-hChR2(H134R)-eYFP (Penn Vector Core; 4.4-
8.5×1012 colony forming units/ml for all viruses). For retrograde tracing experiments we 
injected 20-40 nl of 2% FluoroGold (Fluorochrome, Denver, CO, USA) or 0.5% Cholera 
toxin B subunit (List Biologicals, Campbell, CA, USA) into the target areas. The 
coordinates for the injections were defined by a stereotaxic atlas (72); the null coronal 
plane of the anteroposterior axis was defined by the position of Bregma; the null sagittal 
plane of the mediolateral axis was defined by the sagittal suture; the null horizontal plane 
of the dorso-ventral axis was defined by the bregma and lambda. The injection 
coordinates were the following (always given in mm at the anteroposterior, mediolateral 
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and dorsoventral axes, respectively): nucleus incertus: -5.0, 0.0, -4.2; hippocampus: 
(SOM-Cre, 4-4 injections bilaterally) -2.5, +/- 1.5, -2.1 and -1.5; or -2.0, +/-1.3, -2.0 and -
1.5; (WT HIPP-HIPP retrograde tracing, 3-3 injections unilaterally per tracer) -2.0, +/-
1.5, -1.7; or -2.7, +/-2.2, -1.8; or -3.3, +/-3.0, -2.7; (WT MS-HIPP retrograde tracing, 2-2 
injections bilaterally) -2.0, +/-1.5, -1.7; or -3.0, +/-3.0, -3.0; MS: +1.0, 0.0, -4.3; 
subiculum: -4.2, +/-3.0, and -3.5.  
 
Definition of the area of nucleus incertus 
In the brainstem reticular formation, borders of “nuclei” are not well-defined. For 
instance, NI is best defined by neurons expressing relaxin-3 mRNA/peptide (28, Figure 
1). Although relaxin-3 immunostaining is better detected in nerve terminals in the region, 
relaxin-3 positive neurons are scattered several tens of micrometers outside the NI 
“borders” defined by the Allen Brain Atlas (28, Figure 1), while dendritic arrays of NI 
neurons cross all these putative borders as well. However, in mice the NI is still a 
relatively small area located below the 4th ventricle, occupying about 500 and 1000 µm 
in antero-posterior and lateral axes, respectively, which functionally belong to the same 
cell population. Putative borders, defined by the Allen Brain Atlas, indicated here are 
given only as a reference, because the region is recognized more easily this way. 
 
Hippocampal cranial window implants for two-photon imaging experiments 
Mice spent at least 3 days post injection in their home cages to recover, and then 
were surgically implanted with an imaging window/head-post implant as described (16). 
Briefly, under isoflurane anesthesia, a 3-mm diameter craniotomy was made in the 
exposed skull over the left dorsal hippocampus. After gentle removal of the dura, the 
underlying cortex was slowly aspirated with continuous irrigation with chilled ACSF 
until fibers of the corpus callosum were exposed. A custom-made sterilized cylindrical 
steel imaging cannula with a glass cover slip window (3-mm diameter × 1.5-mm height, 
as described in (41) was inserted into the craniotomy and was cemented to the skull with 
dental acrylic (Unifast Trad) along with a stainless-steel headpost for head-fixation. 
Buprenorphine analgesia (0.05-0.1 mg/kg, sc.) was administered during the procedure 
and for three days after the surgery to minimize post-operative discomfort. 
 
Optic fiber implantations for behavioral experiments 
The highly-specific manipulation of GABAergic neurons in the NI area was 
achieved by the combination of three factors: (1) we infected only GABAergic cells in 
vGAT-Cre mice, (2) we infected only the area of the NI (which was confirmed 
anatomically), and (3) optic fibers targeted only the NI or the hippocampus (Fig. S4). The 
highly restricted infection or specific optic stimulations would have been sufficiently 
selective individually, but their combination ensures the best possible specificity.  
For behavioral experiments, during a second surgical procedure 5-6 weeks after 
virus injections, optic fibers (105 μm core diameter, 0.22 NA, Thorlabs GmbH, 
Dachau/Munich, Germany) were implanted into the brain with the tip at the following 
coordinates: nucleus incertus: -5.0, 0.0, -4.1; hippocampus: -2.5, +/-2.2, -1.7. For secure 
fixture of the implantable optic fiber, 3 screws were inserted into the skull followed by 
disinfection and drying the surface with 70% ethanol and finally, dental cement (Paladur, 
M+W Dental, Hungary) was added between the skull and the base of the ceramic ferrule 
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of the fiber implant (Precision Fiber Products, CA, USA). Positions of the optic fibers are 
illustrated in Fig. S4A-B. After the surgeries, mice received 0.5-0.7 ml saline and 0.03-
0.05 mg/kg meloxicam (Metacam, Boehringer Ingelheim, Germany) intraperitoneally, 
and were placed into separate cages until further experiments or perfusions. 
 
Stereotaxic surgeries for electrophysiological recordings in freely moving mice 
Anesthesia of AAV2/5-EF1a-DIO-hChR2(H134R)-YFP-WPRE transfected vGAT-
IRES-Cre male mice (time interval between virus injection and surgery: 102±42 days) 
was induced by intraperitoneal injection of ketamine-xylazine (4 to 1) combination 
diluted (1:6) in Ringer’s lactate solution (10 ml/kg body weight) and maintained by 
isoflurane during head fixation in the stereotaxic frame. After local disinfection by 
Betadine and local analgesia by 10% lidocaine-spray (both from Egis Pharmaceuticals 
PLC, Budapest, Hungary), the cranium was exposed and cleaned for application of 
adhesive agent (OptiBond XTR, Kerr Corporation, Orange, CA). After photocuration, 
stereotaxically-guided craniotomies were performed for implantation of the optical fiber 
(105 μm core diameter, 0.22 NA, Thorlabs GmbH, Dachau/Munich, Germany) above the 
nucleus incertus (-5.4, 0.0 with tip -3.1 mm from the brain surface) and a multichannel 
(16 or 32) linear type silicon probe (Neuronexus, Ann-Arbor, MI) into the dorsal 
hippocampus (AP -2.5, +2 with tip -2.1 mm from brain surface). Two additional small 
holes were drilled above the cerebellum for stainless steel wires serving as ground and 
reference for the electrophysiological recordings. The optical fiber and a custom-made 
microdrive holding the silicon probe were fixed to the skull using dental acrylate 
(Paladur, Heraeus Kulzer GmbH, Hanau, Germany). The craniotomy above the 
hippocampus was sealed with artificial dura (Cambridge NeuroTech Ltd, Cambridge, 
UK). The probe-microdrive assembly was shielded by a copper mesh preventing the 
contamination of the recordings by environmental electric noise. The mesh was also 
covered by dental acrylate. An additional optical fiber with the tip limited to the dental 
acrylate above the skull was used for control illumination sessions. Before finishing the 
surgery, buprenorphine (0.045 mg/kg body weight) was subcutaneously injected. 
Following all surgeries, the mice were continuously monitored until recovered as 
demonstrated by their ability to exhibit purposeful movements. 
 
Mono-trans-synaptic rabies tracing 
A detailed description of the monosynaptic rabies tracing technique used has already 
been published by Wickersham et al. (42). Briefly, C57Bl/6 and vGAT-Cre mice were 
prepared for stereotaxic surgeries as described above, and 30 nl of the 1:1 mixture of the 
following viruses was injected into the NI at the coordinates given above: AAV2/8-hSyn-
FLEX-TVA-p2A-eGFP-p2A-oG and AAV2/5-CAG-FLEX-oG (4.5×1012 colony 
forming units/ml). These viruses contain an upgraded version of the rabies glycoprotein 
(oG) that has increased trans-synaptic labeling potential (73). After 2-3 weeks of survival, 
mice were injected with the genetically modified Rabies(ΔG)-EnvA-mCherry (3.5×107 
colony forming units/ml) at the same coordinates. After 10 days of survival, mice were 
prepared for perfusions. Cells can be the initiators of transsynaptic spread (starter cells) 
only if they contain both helper viruses (green color) and the rabies viruses (red color). 
We used only those mice, in which starter cells could be found strictly in the area of NI 
only, therefore the transsynaptic spread from the surrounding areas could be excluded, as 
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illustrated in the representative image of Figure 4B. Theoretically, in the area of the 
helper virus injection site, trans-synaptic jumps are possible between cells that are 
interconnected and express the G-protein. It is unknown if these jumps would be able to 
create an efficient starter cell. However, the helper virus injection site is confined to the 
NI area and infected cells can be only GABAergic neurons, because the G-protein 
expressing helper virus is also Cre-dependent. Therefore, initial trans-synaptic jumps are 
theoretically possible only within the area of NI, and it may even be beneficial for 
slightly amplifying starter cell number within NI, however frequently or otherwise it 
occurs. 
 
Antibodies 
The list and specifications of the primary and secondary antibodies used can be 
found in Supp. Table 1-3. The specificities of the primary antibodies were extensively 
tested, using knock-out mice if possible. Secondary antibodies were extensively tested for 
possible cross-reactivity with the other antibodies used, and possible tissue labeling 
without primary antibodies was also tested to exclude auto-fluorescence or specific 
background labeling. No specific-like staining was observed under these control 
conditions. Combinations of the used primary and secondary antibodies in the different 
experiments are listed in Supp. Table 4-5. 
 
Perfusions 
Mice used in 2P imaging experiments were deeply anaesthetized with 2% isoflurane. 
Mice used in all other experiments were anesthetized with 2% isoflurane followed by an 
intraperitoneal injection of an anesthetic mixture (containing 8.3 mg/ml ketamine, 1.7 
mg/ml xylazine-hydrochloride, 0.8 mg/ml promethazinium-chloride) to achieve deep 
anesthesia. The mice were then perfused transcardially (protocol A) with 0.1M 
phosphate-buffered saline (PBS, pH 7.4) solution for 2 min followed by 30 ml of 4% 
freshly depolymerized paraformaldehyde (PFA) solution; (protocol B) with PBS for 2 
min, followed by PFA for 40 min, followed by PBS for 10 min; (protocol C) with 
artificial cerebrospinal fluid (ACSF) for 2 min containing the following reagents (in 
mM): 125.0 NaCl, 2.5 KCl, 25.0 glucose, 1.25 NaH2PO4, 2.5 CaCl2-2H2O, 2 MgCl2-
6H2O and 26 NaHCO3. All salts were obtained from Sigma-Aldrich. After perfusion, 
brains were removed from the skull, and brains perfused using protocols A and B were 
immersion-fixed in 4% PFA with or without 0.2% glutaraldehyde (GA) for 2 h. Brains 
were cut into 50 or 60 μm sections using a vibrating microtome (Leica VT1200S or 
Vibratome 3000). 
 
Fluorescent immunohistochemistry and laser-scanning confocal microscopy 
Perfusion-fixed sections were washed in 0.1 M phosphate buffer (PB, pH 7.4), and 
incubated in 30% sucrose overnight for cryoprotection. Sections were then freeze-thawed 
over liquid nitrogen three times for antigen retrieval. Sections were subsequently washed 
in PB and Tris-buffered saline (TBS, pH 7.4) and blocked in 1% human serum albumin 
in TBS (HSA; Sigma-Aldrich) and then incubated in a mixture of primary antibodies for 
48-72 h. This was followed by extensive washes in TBS, and incubation in the mixture of 
appropriate secondary antibodies overnight. For visualizing cell layers in the 
hippocampus, nuclear counterstaining was done on forebrain sections using Draq5 
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(1:1000, Biostatus) according to the manufacturer`s protocol. Following this, sections 
were subsequently washed in TBS and PB, dried on slides and covered with Aquamount 
(BDH Chemicals Ltd) or with Fluoromount-G Mounting Medium (Invitrogen). For the 
viral injection and retrograde tracing experiments, each injection site was reconstructed 
from 50 µm sections using a Zeiss Axioplan2 microscope. For the retrograde tracing 
experiments, we also estimated what percentage of the injected brain area was labeled 
with the tracer. Every part of the injected tissue containing even low levels of tracer was 
considered as part of the injection site. We fitted every image of the injection sites to the 
corresponding outlines of the atlas (72), and determined the ratio of the volumes of the 
injection sites to the injected brain area, using the Fiji/ImageJ software. The brain areas 
measured were the following based on the atlas: in the hippocampus, the dentate gyrus 
and the regions CA1-3; in the MS, the medial septal area and the vertical diagonal band 
of Broca. Sections were evaluated using a Nikon A1R confocal laser-scanning 
microscope system built on a Ti-E inverted microscope with a 10× air objective or with a 
0.45 NA CFI Super Plan Fluor ELWD 20XC or with a 1.4 NA CFI Plan Apo VC 60× oil 
objective or with a Nikon Ni-E C2+ confocal system equipped with a 0.75 NA Plan Apo 
VC DIC 20× objective, both operated by NIS-Elements AR 4.3 software. Regions of 
interests were reconstructed in z-stacks; distance between the focal planes was 0.5 μm for 
examined synaptic contacts and 2 μm for examined neuronal somata. 
In case of the monosynaptic rabies tracing experiments, coronal sections spaced at 
300 μm were prepared from the whole brain for confocal laser-scanning microscopy, and 
every transsynaptically labeled cell was scanned using a Nikon Ni-E C2+ confocal 
system equipped with a 0.13 NA Plan Fluor 4× objective operated by NIS-Elements AR 
4.3 software. The cell counting was performed using the Adobe Photoshop CS6 software. 
 
Immunogold-immunoperoxidase double labeling and electron microscopy 
Perfusion-fixed sections were washed in 0.1 M phosphate buffer (PB) for 1 hour, 
then cryoprotected by incubation in 30% sucrose overnight and freeze-thawed three times 
over liquid nitrogen. For synaptic detection of gephyrin, sections were washed in 0.1 M 
PB and in TBS and blocked in 1% human serum albumin in TBS (HSA; Sigma-Aldrich), 
followed by incubation in a mixture of primary antibodies for 48-72 h. For synaptic 
detection of GABAA-receptor γ2 subunit, sections were pretreated with 0.2 M HCl 
solution containing 2 mg/ml pepsin (Dako) at 37°C for 8 min. Then sections were 
blocked in 1% HSA in TBS, followed by incubation in a mixture of primary antibodies. 
After repeated washes in TBS, sections were incubated in blocking solution (Gel-BS) 
containing 0.2% cold water fish skin gelatin (Aurion) and 0.5% HSA in TBS for 1 h. 
Sections were then incubated in mixtures of secondary antibody solutions overnight. 
After intensive washes in TBS, the sections were treated with 2% glutaraldehyde in 0.1 
M PB for 15 min to fix the gold particles in the tissue. To develop the labeling for NI 
fibers, this was followed by incubation in avidin-biotinylated horseradish peroxidase 
complex (Elite ABC; 1:300; Vector Laboratories) diluted in TBS for 3 h. The 
immunoperoxidase reaction was developed using 3-3′-diaminobenzidine (DAB; Sigma-
Aldrich) as chromogen. To enlarge immunogold particles, this was followed by 
incubation in silver enhancement solution (SE-EM; Aurion) for 40-70 min at room 
temperature. The sections were treated with 0.5% osmium tetroxide in 0.1 M PB on ice 
and they were dehydrated in ascending alcohol series and in acetonitrile and embedded in 
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Durcupan (ACM; Fluka). During dehydration, the sections were treated with 1% uranyl-
acetate in 70% ethanol for 20 min. After this, 70-100 nm serial sections were prepared 
using an ultramicrotome (Leica EM UC6) and collected on single-slot copper grids. 
Sections were examined using a Hitachi H-7100 electron microscope and a Veleta CCD 
camera driven by the iTEM 5.0 software (Olympus). Randomly sampled terminals of the 
NI establishing synaptic contacts in the HIPP and MS were always fully reconstructed. 
 
Silver-gold intensified and nickel-intensified immunoperoxidase double labeling (SI-
DAB/DAB-Ni) 
Perfusions, sectioning and incubations of sections in primary antibody solutions 
were performed as described. The SI-DAB reaction was followed by subsequent washes 
in the appropriate secondary antibody solutions for 24h in TBS. After subsequent washes 
in TBS and incubation in avidin-biotin-peroxidase complex for 3 h (ABC Elite 1:300, 
Vector Laboratories), ammonium nickel sulphate-intensified 3-3’-diaminobenzidine 
(DAB-Ni) was used for the development of immunoperoxidase reaction. This reaction 
was further intensified with silver-gold (SI/DAB) as described in detail in Dobó et al. 
(74). This intensification step converts the labeling from homogenous to granular by 
loading fine gold particles onto the DAB-Ni deposit. After washes in TBS, sections were 
blocked in 1% HSA for 1 h and incubated in primary antibody solutions for the second 
DAB-Ni reaction for 48-72 h. This step was followed by incubation with ImmPRESS 
secondary antibody solutions overnight. The second immunoperoxidase reaction was 
developed by DAB-Ni, resulting in a homogenous deposit, which was clearly 
distinguishable from the silver-gold intensified SI-DAB at the electron microscopic level 
(74). Further dehydration, contrasting and processing of the sections for electron 
microscopy was performed as described above. 
 
In vitro slice preparation 
In all slice studies, mice were decapitated under deep isoflurane anesthesia. The 
brain was removed and placed into an ice-cold cutting solution, which had been bubbled 
with 95% O2/5% CO2 (carbogen gas) for at least 30 min before use. The cutting solution 
contained the following (in mM): 205 sucrose, 2.5 KCl, 26 NaHCO3, 0.5 CaCl2, 5 
MgCl2, 1.25 NaH2PO4, 10 glucose. After this, 300-450 µm horizontal slices of ventral 
hippocampi or 300 µm coronal brainstem slices containing the nucleus incertus were cut 
using a Vibratome (Leica VT1000S). After acute slice preparation, slices were placed in 
an interface-type holding chamber for recovery. This chamber contained standard 
artificial cerebrospinal fluid (ACSF) at 35°C that was gradually cooled to room 
temperature. The ACSF solution contained the following (in mM): 126 NaCl, 2.5 KCl, 26 
NaHCO3, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4 and 10 glucose, saturated with carbogen 
gas. All salts and drugs were obtained from Sigma-Aldrich or Molar Chemicals LTD. 
 
Intracellular recordings 
The composition of the intracellular pipette solution was the following (in mM): 110 
K-gluconate, 4 NaCl, 20 HEPES, 0.1 EGTA, 10 phosphocreatine, 2 ATP, 0.3 GTP, 3 
mg/ml biocytin adjusted to pH 7.3–7.35 using KOH (285–295 mOsm/L). Whole-cell 
series resistance was in the range of 5–15 MΩ. Series resistance was not compensated but 
was frequently monitored, and cells where the values changed more than 25% during 
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recording were discarded from further analysis. Voltage measurements were not 
corrected for the liquid junction potential. To record GABAergic currents, membrane 
potential was clamped far (~0 mV) from GABA reversal potential. In case of intracellular 
recordings, fast glutamatergic transmission was blocked by adding the α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-receptor antagonist NBQX (20 
μM; Hello Bio Inc.) and the N-methyl-D-aspartate (NMDA)-receptor antagonist AP-5 
(50 μM; Tocris Bioscience) to the recording solution. To test GABAA-receptor 
dependent synaptic transmission, we administered the GABAA-receptor antagonist 
gabazine (5 μM; Tocris Bioscience) into the ACSF. All drugs were administered from 
stock solutions via pipettes into the ACSF containing superfusion system. For ChR2 
illumination, we used a blue laser diode (447 nm, Roithner LaserTechnik GmbH) 
attached to a single optic fiber (Thorlabs) positioned above the hippocampal slice. For 
ArchT illumination, we used a red laser diode (640 nm, iBeam smart, Toptica Photonics) 
with optic fiber positioned above NI. Cells recorded in current clamp configuration were 
depolarized above firing threshold to test the effectivity of ArchT mediated inhibition on 
action potential generation. 
 
Digital signal processing, analysis and statistics for in vitro experiments 
All data were processed and analyzed off-line using self-developed programs written 
in Python 2.7.0 and Delphi 6.0 by A.I.G. and D.S. In every in vitro experiment, we used 
median and 25%-75% interquartile range to describe data groups because they did not 
display a Gaussian distribution.  
 
In vivo two-photon calcium imaging 
Calcium imaging in head-fixed, behaving mice was performed using a two-photon 
microscope equipped with an 8 kHZ resonant scanner (Bruker) and a Ti:Sapphire laser 
(Chameleon Ultra II, Coherent) tuned to 920 nm. For image acquisition we used a Nikon 
40× NIR Apo water-immersion objective (0.8 NA, 3.5 mm WD) coupled to a piezo-
electric crystal (Bruker). To adjust the angle of the imaging window to the plane of the 
front lens of the objective, we set the angle of the fixed-head with two goniometers 
(Edmond Optics). Fluorescent signals were collected by a GaAsP photomultiplier tube 
(Hamamatsu 7422P-40) at 1-1.5 × digital zoom covering 300 × 300 m - 200 × 200 m 
with 512 × 512 pixels per imaging plane. To minimize the loss of bouton calcium signals 
caused by z-motion of the brain, we imaged from 5 planes separated by 2 m in z at 5 
Hz. 
 
Behavior for two-photon calcium imaging 
For the in vivo head-fixed 2P calcium-imaging experiments, behavioral training of 
the mice was started three days after implantation surgery. Mice were hand habituated, 
water restricted (>90 percent of their pre-deprivation body weight) and trained for 5-7 
days to run on a 2 m-long cue-less burlap belt on a treadmill for water rewards, while 
being head-fixed (gradually decreasing the number of reward zones from 15 covering the 
full length of the belt to randomly delivered 3 water rewards). Mice were also habituated 
to the 2P setup and the scanner and shutter sounds prior to the actual 2P imaging 
experiments. The treadmill was equipped with a lick-port for water delivery and lick 
detection. Locomotion was recorded by tracking the rotation of the treadmill wheel using 
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an optical rotary encoder (256 CPR, Bourns). Stimulus presentation and behavioral read-
out were driven by microcontroller systems (Arduino), using custom made electronics. 
During random foraging experiments three water rewards were presented per lap in 
random locations, while mice were running on a cue-less burlap belt. In salience 
experiments, discrete stimuli were presented as described (41), with slight modifications. 
Air-puff (duration: 200 ms, flow rate: 4 LPM), water (duration of valve opening: 200 
ms), light (duration: 200 ms, red LED) and tone (duration: 200 ms, frequency: 2500 Hz, 
from one speaker below the mice) were presented randomly within a 5 s stimulus time, 
the pre-stimulus time was 5 s, the post-stimulus time was 15 s. Stimuli were repeated 10× 
for each modality in a pseudorandom order during one experiment. 
 
Two-photon calcium imaging data pre-processing 
The acquired 2P imaging data were pre-processed for further analysis using the 
SIMA software package (76). Motion correction and extraction of dynamic GCaMP6f 
fluorescent signals were conducted as described (77). Regions of interest (ROIs) were 
drawn manually over the time-averages of motion corrected time-series to isolate the 
bouton calcium signals of GCaMP6f-expressing axons. Any imaging frames with 
residual motion artifacts were excluded from further analysis. Relative fluorescence 
change (ΔF/F) was calculated by first smoothing the raw fluorescence trace for each ROI 
with a first-order Savitzky-Golay filter (60 window) to estimate baseline fluorescence. 
The baseline was then subtracted from the lightly filtered raw fluorescence (1 second 
window), which was divided by the baseline to obtain ΔF/F. 
 
Analysis of two-photon calcium imaging data 
Bouton responses. Peri-event time histograms (PETHs) and peri-stimulus time 
histograms (PSTHs) were calculated by extracting each bouton’s ΔF/F in a window 
around the onset of each event/stimulus (plotted as -5 to +10 sec around the onset). For 
the data presented in Fig. 3, we first averaged each ROI’s responses across all iterations 
of the stimulus/event, and then plotted the grand mean of responses across ROIs with a 
99% confidence interval via bootstrap resampling. Only boutons with significant 
responses to the stimulus were included in the plotted PETHs in Fig. 3E or PSTHs in Fig. 
3F.  
Bouton response significance. We assessed whether a bouton was significantly 
modulated by each stimulus/event by a bootstrap test. For each presentation of a stimulus 
or event for a ROI, we calculated the change in fluorescence from five seconds before 
presentation (Pre) to five seconds after (Post). We then calculated a bootstrapped 
confidence interval on the average change in fluorescence during stimulus presentation 
by bootstrap resampling. P-values for each stimulus/ROI pair were calculated as 1 minus 
the fraction of bootstrapped averages greater than zero (less than zero for the run-stop 
analysis). ROIs were considered to have a significant response to a stimulus/event if the 
bootstrapped p-value was < 0.05. This threshold is marked on the summary plots in Fig. 
3H-I to denote the proportion of ROIs expected to display significance by chance. We 
calculated each proportion from the total population of ROIs that responded to at least 1 
stimulus, to exclude the fraction of boutons in the FOVs that did not display significant 
dynamics. 
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Statistics for two-photon calcium imaging 
Statistical differences in bouton fluorescence when mice were stationary and 
running was tested via Wilcoxon signed-rank test. PSTH significance for each ROI/event 
pair was determined by a bootstrap test as described. Z-tests were used to compare ROI 
proportions using the Bonferroni procedure to correct p-values for multiple comparisons, 
where appropriate.  
Jaccard similarity test was carried out on data presented in Fig 3J to assess the 
significance of the overlap in ROI populations activated by each stimulus pair. Using a 
permutation test, we tested whether the overlap between the ROIs recruited by each 
stimulus is any less than what we would expect from random selection of ROIs from the 
population. We report the p-values from the procedure above for all stimulus pairs. 
 
Optogenetics and contextual fear conditioning (CFC) 
After optic fiber implantations, mice were transferred to the animal room of the 
behavioral unit, where they received 5 days of handling. Behavioral experiments were 
performed in a separate experimental room. On the 6th day, mice were placed into the 
first environmental context (environment “A”) in a plexiglass shock chamber (25 cm × 
25 cm × 40 cm) that was enriched with a specific combination of cues - olfactory (citrus 
scent), visual (black and white striped wall), spatial (square-shaped chamber), auditory 
(white noise) and tactile (metal bars on the floor). Mice were allowed to freely move in 
the first environment for 2 min to record baseline freezing levels. Mice were considered 
to display freezing behavior, if they did not make any movement other than breathing for 
at least 2 seconds. After this, mice received 4 foot-shocks (2 seconds, 1-2 mA intensity, 
30 seconds inter-shock interval). Optogenetic stimulation (15 mW intensity at the tip of 
the optic fiber, 5 ms blue laser light pulses at 25 Hz for 6 seconds, at 473 nm wavelength) 
was precisely aligned with the shocks, starting 2 seconds before shock onset and finishing 
2 seconds after shock offset. For the “ChR2-shifted” group, this laser stimulation was 
shifted by 15 seconds after shock onset. Foot shocks and laser pulses were driven by a 
custom-made TTL pulse generator (Supertech Instruments). After four successfully 
delivered shocks, mice were placed back into their home cages for 24 h. On the 7th day, 
mice were placed back into the first environment for 3 minutes to record freezing 
behavior. (The shock chamber was cleaned thoroughly with citrus soap between mice). 
This was followed by 5 days of extensive handling to achieve full fear extinction that 
reset freezing behavior to a normal baseline. On the 13th day, mice were placed into the 
second environmental context (environment “B”), composed of another set of cues - 
olfactory (macadamia nut scent), visual (black dotted walls with white background), 
spatial (bended chamber walls), auditory (no noise) and tactile (metal bars on the floor) 
cues. Baseline freezing levels were recorded for 3 minutes, followed by 4 shocks without 
optogenetic stimulation. After receiving the shocks, mice were placed back into their 
home cages and the shock chamber was cleaned thoroughly with macadamia nut soap. 
Then 24 h later, on the 14th day, freezing behavior was recorded in the second 
environment for 3 minutes. The behavior of the mice was recorded with a JVC GC-
PX100 camcorder, and freezing behavior was analyzed manually using the Solomon 
Coder software. We considered freezing behavior periods as those when mice displayed 
only respiration-related movements for at least 2 seconds. The experimenter evaluating 
freezing levels was blinded to the conditions and history of the mice. Mice showing 
  
11 
 
higher than 5% baseline freezing levels in environment “A” were excluded from further 
analysis. 
 
Optogenetics and delay cued fear conditioning (CuedFC) 
After optic fiber implantations, mice were transferred to the animal room of the 
behavioral unit of the institute, where they received 5 days of handling. On the 6th day, 
mice were placed into the first environmental context (environment “A”) in a plexiglass 
shocking chamber (25 cm × 25 cm × 31 cm) that was enriched with a specific 
combination of cues - olfactory (macadamia nut scent), visual (black dotted wall with 
white background), spatial (bended chamber walls), auditory (white noise) and tactile 
(metal bars on the floor). Mice were allowed to freely move in the first environment for 3 
minutes to record baseline freezing levels. After this, mice received 3 shocks (2 seconds, 
2 mA intensity, 60 seconds inter-shock interval) that were paired with an auditory cue 
(30s long sound at 7500 kHz). The footshocks and the auditory cues were co-terminated 
each time. After receiving the last shock, mice were kept in the context for another 30 
seconds. During the experiment, lasting 6 minutes, mice received a continuous yellow 
laser light illumination (15 mW intensity at the tip of the optic fiber at 593 nm 
wavelength). After 3 successfully delivered shocks, mice were placed back into their 
home cages for 24 h. On the 7th day, mice were placed back into the first environment 
for 3 minutes to record freezing behavior related to the contextual fear memories. Then 
24 h later, on the 8th day, mice were placed into a second environmental context 
(environment “B”) with distinct cues - olfactory (citrus scent), visual (black and white 
striped wall), spatial (square shaped chamber), auditory (no noise) and tactile (plastic 
floor). Here, after 3 minutes mice were presented with the auditory cue for 1 minute to 
record freezing behavior related to the cued fear memories. The behavior of mice was 
recorded with a JVC GC-PX100 camcorder, and freezing behavior was analyzed 
manually using the Solomon Coder software. The experimenter evaluating freezing levels 
was blind to the conditions of the mice. Mice displaying higher than 5% baseline freezing 
levels in environment “A” were excluded from the further analysis. 
 
Elevated plus maze (EPM) after optogenetic CFC 
One (1) hour after freezing behavior assessment in the first environment (7th day) 
we placed the mice into an EPM to test their anxiety levels. The cross-shaped EPM 
apparatus consisted of two open arms with no walls (30 cm × 7 cm) and two closed arms 
(30 cm high walls) and was on a pedestal 50 cm above floor level (Fig. 6A). The 
behavior of the mice was recorded with a JVC GC-PX100 camcorder and evaluated using 
an automated system (Noldus Ethovision 10.0; Noldus Interactive Technologies). 
Behavior was measured as total time in the open and closed arms. 
 
Statistics for optogenetic behavioral experiments 
In every behavioral experiment, we used median and 25%-75% interquartile range 
to describe data groups, because they did not display a Gaussian distribution. To test for 
statistically significant differences in independent data populations, we used the Mann-
Whitney U-test, and in dependent data populations, we used the two-sided Wilcoxon 
signed-rank test. 
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In vivo electrophysiological recordings in freely behaving mice 
Electrophysiological recordings were commenced after a 7-day post-surgery 
recovery and habituation to ‘connectorization’. The signal from the silicon probe was 
multiplexed by RHA2132 chip (Intan Technologies, Los Angeles, CA, USA) and 
transmitted through a lightweight flexible cable to the signal acquisition system (KJE-
1001, Amplipex Ltd, Szeged, Hungary) at 20 kHz sampling rate. The movement of the 
mouse was tracked by a marker-based, high speed (120 frame/s) 4-camera motion capture 
system and reconstructed in 3D (Motive, OptiTrack, NaturalPoint Inc, Corvallis, OR, 
USA). The markers needed for tracking were attached to the headstage connected to the 
silicon probe and to the shielding mesh. After home cage recording, mice were placed 
into an open arena (40 × 60 cm) and into a linear track (100 × 9 cm). Recordings were 
repeated 1-7 days later. In each recording situation, blue (473 nm) light stimulation was 
triggered manually by the experimenter controlling the TTL pulse generator (Spike2 and 
micro1401mkII, CED Ltd, Cambridge, UK). Various trains of 5 ms long TTL pulses 
were used: constantly repeating at 5, 15 or 25 Hz frequency (50-100 pulses in total per 
session) or delivered in a theta burst protocol (TBS, 3 or 5 pulses at 25 or 50 Hz in bursts 
repeated at 5 or 10 Hz). TTL pulses were fed into the power supply of the laser (IKE-
473-LN-100T with a power supply (IKE-PS-300, IkeCool Corp, Anaheim, CA, USA) 
coupled to a 105 μm core diameter multi-mode patch cable (Thorlabs GmbH, 
Dachau/Munich, Germany) terminating in a ceramic ferrule. This ferrule was connected 
by a ceramic mating sleeve to either the incertus-implanted or the control optical fiber, 
plus the mating sleeve was covered by a small black plastic tube to minimize the light 
leakage. The light intensity at the tip of the fiber was approximately 9-13 mW prior to 
recordings. Mice were recorded in 3 - 9 sessions for 2 - 5 weeks. Mice were perfused 
transcardially with 4%PFA after the electrophysiological recordings were completed, and 
the brains were processed for histological verification of the viral transduction zone and 
implantation. Data from mice with confirmed transduction, optical fiber position and 
silicon probe track colored by DiI (Molecular Probes, Cat. No.: D282) prior to the 
implantation were used in the analysis (n = 5). 
 
Data analysis and statistics for in vivo experiments 
The analysis was performed in MATLAB environment (MathWorks, Natick, MA, 
USA) by custom-written functions and scripts. Local field potential (LFP) signal was 
downsampled at 1 kHz. Channels from strata pyramidale, radiatum, lacunosum-
moleculare, moleculare and hilus were identified by characteristic physiological markers 
(amplitude of ripple activity, reversal of sharp-waves, phase-shift of theta oscillation and 
sink-source distribution on current source density profiles) and probe track location in 
histological preparations. The instant speed of the mouse was calculated from the 3D-
tracked position data synchronized to the LFP recordings. To reduce the velocity noise, 
the harmonic mean of instant speed (calculated by overlapping 11-sample sliding 
segments, omitting speed data when the increment of instant acceleration was more than 
5-fold) smoothed by a Savitzky-Golay filter (occasional negative values in the result were 
replaced by the linear interpolation between surrounding positive values) was used in the 
analysis. The stimulation sessions were categorized by whether the mouse was running or 
sleeping in REM state at the illumination onset. The criteria for running episodes were: 
(a) average speed of the mouse in 4 subsequent 0.5 s long time segments preceding the 
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stimulus onset above 4 cm/s and (b) higher power in theta band (5-12 Hz) than in delta 
band (1-4 Hz) assessed by the Welch’s power spectral density estimate (periodogram) of 
the pyramidal LFP in the 2 s preceding the stimulus onset. The criteria for REM sleep 
episodes were: (a) absence of synchronous activity in the 300-1000 Hz band of LFP 
across all neighboring channel pairs, (b) average speed below 4 cm/s and (c) higher 
power in theta band than in delta band of LFP (the last two criteria were measured by the 
same method as detailed above in the running definition). Running episodes were pooled 
together from recordings made in the open arena and linear track, REM episodes were 
identified in home cage recordings. LFP changes in the pyramidal layer of CA1 induced 
by the optical stimulations were assessed by the ratio of spectral power distribution 
calculated by Welch’s overlapped segment averaging estimator during the illumination 
and the preceding 2 s. Changes in low (5-8 Hz) and high theta (8 - 12 Hz) band activity 
(spectral power was summed in the given frequency range) among different stimulation 
protocols were compared by one-way Kruskal-Wallis ANOVA followed by Tukey’s 
honestly significant difference procedure. The effects of the stimulation protocol that 
evoked significantly stronger power change in the high theta band than other in protocols 
(i.e., 25 Hz stimulation conducted in n = 4 mice, both NI GABAergic neuron and control 
illumination) were detailed in further analysis steps. In addition to low and high theta 
band, spectral power changes of the pyramidal LFP in the range of slow gamma (here 
restricted to 30-45 Hz to exclude rhythms generated by the repeating light-pulse-evoked 
transients at 25 Hz and its harmonics such as 50 Hz) and mid gamma (60-100 Hz) were 
also examined. Time-frequency decomposition of pyramidal LFP with continuous 
wavelet transform (78) and subsequent bias correction of spectral power (79) was used to 
calculate instant power. Pairing of instant power and speed data during stimulation, and 
the preceding and following 4 s allowed us to disparately examine the changes in the low 
and high theta band power when mice were quiet (instant speed: 0-4 cm/s) and moving 
(instant speed > 4 cm/s). Current source density (CSD) maps were calculated to uncover 
electric responses upon stimulation in more superficial layers of CA1 such as stratum 
radiatum and lacunosum-moleculare and in the dentate gyrus. For CSD analysis, noisy 
and low impedance channels were excluded manually. Pulse-onset-triggered CSD 
averages were calculated in ±100 ms around the onset of light pulses during stimulation, 
and for the preceding 2 s, the intervals of the original pulse train were shifted with a 
random start time. Theta-peak-triggered CSD averages were calculated in ±250 ms 
around the peaks of theta cycles (the phase was computed from the Hilbert transform of 8 
- 12 Hz band filtered pyramidal LFP signal) when instant power of pyramidal theta 
oscillation was higher than that of delta (the power ratio was computed from bias-
corrected time-frequency decomposition of LFP with continuous wavelet transform). For 
assessment of stimulation-induced current changes, data were temporally (in ±10 ms 
around the maximal sink following the onset of pulses or the peaks of theta cycles) and 
spatially (channels in the same layer of hippocampus) averaged. For visualization 
purposes only, CSD maps were smoothed by a Gaussian filter after 100-times linear 
interpolation between each channels. For statistical comparisons of in vivo physiological 
data, non-parametric two-sided Wilcoxon rank sum (control vs. NI GABAergic neuron 
stimulation) and signed-rank tests (before vs. during stimulation or during vs. after 
stimulation) were used. 
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Data and code availability  
Data generated and analysed during the current study are presented in the 
manuscript or in the Supplementary Materials file, while additional datasets and custom 
written codes for in vivo electrophysiological recordings, 2P-imaging and data analysis 
are available from the following links: https://figshare.com/s/9fb345fc23ac2ac94fcd and 
https://figshare.com/s/5b0c6be2431caf10272b 
 
Supplementary Text for Main Figures 1-6 
 
Supplementary Data for Main Fig. 1 
Figure 1C: The vast majority of eYFP-positive fibers was positive for relaxin-3 (at 
least 194/210) and vGAT (at least 351/357, white arrowheads), and the majority of the 
relaxin-3 positive boutons also contained eYFP- (at least 388/410) and vGAT-positivity 
(at least 402/410), indicating that effectively all relaxin-3-containing fibers targeting the 
hippocampus originate from the NI. 
Figure 1D: Synapses established by the NI were positive for the GABAA-receptor 
γ2 subunit (at least 35/48, upper row) and the scaffolding protein gephyrin (at least 55/62, 
lower row). The sizes of synapses established by NI neurons were measured on the 
immunoreactions for gephyrin, on fully reconstructed synapses from 70 nm thick serial 
sections. Synapse areas are given (in µm2) as follows (median [25%-75% quartiles]): 
CA1 (n=19): 0.22 [0.12-0.39]; hilus (n=17): 0.22 [0.19-0.25]. 
Figure 1I: The majority of relaxin-3 positive NI fibers establish synaptic contacts 
marked by gephyrin on SOM-positive interneurons in the hippocampus (at least 
264/424). 
Figure 1J: The in vitro recorded neurons in the stratum oriens (n=18) were post-hoc 
characterized morphologically (6 O-LM cells [4 of them confirmed SOM positive], 4 
projection cells, 1 bistratified cell, 7 unidentified cells) and neurochemically (at least 
12/18 SOM-positive cells). 
Figure 1N: IPSC amplitudes (in pA) are as follows (median [25%-75% quartiles]): 
control (red): 32.74 [30.75-44.59], gabazine (blue): 0 [0-0], washout (yellow): 18.45 
[11.91-25.25]. 
 
Supplementary Data for Main Fig. 2 
Figure 2C: The majority of eYFP-positive fibers was positive for relaxin-3 (at least 
154/241) and vGAT (at least 212/241), and the majority of the relaxin-3 positive boutons 
also contained eYFP- (at least 169/190) and vGAT-immunoreactivity (at least 187/190), 
indicating that effectively all relaxin-3-containing fibers targeting the hippocampus arise 
from the NI. 
Figure 2D:  NI synapses in the MS, contained the GABAA-receptor γ2 subunit (at 
least 28/28, upper row) or the scaffolding protein gephyrin (at least 43/44, lower row. 
The sizes of synapses established by NI were measured on the basis of immunoreactions 
for gephyrin, on fully reconstructed synapses from 70 nm serial sections. Synapse areas 
are given (in µm2) as follows (median [25%-75% quartiles]): MS (n=32): 0.24 [0.19-
0.29]. 
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Figure 2F: At least 148/270 relaxin-3 positive terminals established synapses with 
vGluT2-positive profiles. The majority of medial septal vGluT2-positive cells received at 
least one such contact in the examined area (at least 45/80 counted cells). 
Figure 2H: At least 21/280 relaxin-3 positive terminals contacted ChAT-positive cell 
profiles. Medial septal ChAT-positive neurons received at least one such contact in the 
examined area (at least 14/38 counted cells). 
 
Supplementary Data for Main Fig. 4 
Figure 4C: Abbreviations: A24a: cingulate cortex area 24a; A24b: cingulate cortex 
area 24b; ATg: anterior tegmental nucleus (Gudden); DMTg; dorsomedial tegmental 
nucleus; DR: dorsal raphe; DTg: dorsal tegmental nucleus; Gi: gigantocellular nucleus; 
HDB: horizontal limb of the diagonal band of Broca; iRt: isthmic reticular formation; 
LDTg: laterodorsal tegmental nucleus; LH: lateral hypothalamus; LHb: lateral habenula; 
LPo: lateral preoptic area; MM: mammillary bodies; MRR: median raphe region; mRt: 
mesencephalic reticular formation; MS:medial septum; NPr: nucleus prepositus; PAG: 
periaqueductal grey matter; PH: posterior hypothalamus; PNO: nucleus pontis oralis; 
SIB: substantia innominata of the basal forebrain; SUM: supramammillary nucleus; 
VDB: vertical limb of the diagonal band of Broca; VTA: ventral tegmental area; ZI: zona 
incerta 
 
Supplementary Data for Main Fig. 6 
Figure 6A: Population data for the freezing levels (in % of total time) in the 
environment ”A” for n=9 ChR2 and n=10 CTRL mice that received foot-shock-aligned 
stimulation of NI are as follows: (median [25%-75% quartiles]): ChR2: 1.22 [0.00-2.45], 
CTRL: 13.63 [5.01-21.36] (**: p=0.003, Mann-Whitney U-test). 
Population data for the time spent in open arms of the EPM (in seconds) for n=7 
ChR2 and n=10 CTRL mice that received foot-shock-aligned stimulation of NI are as 
follows: (median [25%-75% quartiles]):  ChR2: 34.36 [18.64-97.44], CTRL: 12.00 [0.88-
23.76] (*: p=0.022, Mann-Whitney U-test). 
Figure 6B: Population data for the freezing levels (in % of total time) for n=21 
ChR2 mice that received foot-shock-aligned stimulation of NI fibers in the HIPP, are as 
follows: (median [25%-75% quartiles]): environment ”A”: 3.67 [2.22-6.34], environment 
”B”: 12.01 [4.78-18.24] (**: p=0.007, Wilcoxon signed-rank test). 
Population data for the freezing levels (in % of total time) for n=14 CTRL mice that 
received foot-shock-aligned stimulation of NI fibers in the HIPP are as follows: (median 
[25%-75% quartiles]): environment ”A”: 6.67 [0.00-19.02], environment ”B”: 15.63 
[5.90-18.13] (n.s.: non-significant, p=0.196, Wilcoxon signed-rank test). 
Figure 6C: Population data for the freezing levels (in % of total time) for n=6 ChR2-
light-aligned and n=6 ChR2-light-shifted mice, are as follows: (median [25%-75% 
quartiles]):  ChR2-aligned: 4.34 [2.22-6.56], ChR2-shifted: 20.86 [8.79-25.36] (**: 
p=0.008, Mann-Whitney U-test).  
Figure 6D: Population data for the contextual freezing levels (in % of total time) in 
the environment ”A” for n=5 ArchT and n=6 CTRL mice are as follows: (median [25%-
75% quartiles]):  ArchT: 15.11 [13.67-17.56], CTRL: 6.11 [4.11-8.67] (*: p=0.022, 
Mann-Whitney U-test). 
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Population data for the cued freezing levels (in % of total time) in the environment 
”B” for n=5 ArchT and n=6 CTRL mice are as follows: (median [25%-75% quartiles]):  
ArchT: 36.50 [33.33-39.67], CTRL: 40.33 [32.00-52.67] (n.s.: non-significant, p=0.784, 
Mann-Whitney U-test).  
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Fig. S1. Supplementary anatomical details of NI GABAergic neuronal projections  
 
 
A: Double retrograde tracing in the bilateral hippocampi using FG in the right and CTB 
in the left hemisphere, respectively, in C57Bl/6 wild-type mice (n=2). 
B: A representative injection site illustrating green FG labeling and red CTB labeling in 
the hippocampi of right and left hemispheres, respectively. Scale bar: 500 μm. 
C: FG labeled neurons (green, cyan arrowheads) and CTB labeled neurons (red, magenta 
arrowheads) are mainly located in the ipsilateral NI, in the right or left hemisphere, 
respectively. Only a few NI neuron were positive for both retrograde tracers (18/315). 
The majority of the retrogradely-labeled neurons was relaxin-3 positive (white, 222/315). 
Scale bar: 100 μm. 
D: AAV2/5-EF1α-DIO-eYFP was injected into the NI of vGAT-tdTomato reporter mice 
(n=2). 
E: Electron microscopic images reveal SI-DAB (grainy precipitate) containing NI fibers 
establishing symmetrical synaptic contacts (black arrows) with DAB-Ni (dark precipitate, 
false-colored with faint red) containing hippocampal interneuron dendrites (d) and 
somata (s). The majority of NI fibers established synaptic contacts with DAB-Ni positive 
GABAergic profiles (total: 62/71, 55 on dendrites, 7 on somata). Scale bar: 600 nm. 
F: AAV2/5-EF1α-DIO-eYFP was injected into the NI of vGAT-Cre mice (n=7). 
G: NI fibers labeled with eYFP (green) establish putative contacts (white arrowheads) 
with SOM-positive (red) and mGluR1α-positive (white) interneurons in the stratum 
oriens of the dorsal CA1. Scale bar: 20 μm. 
H: Many of the SOM-positive interneurons are parvalbumin (PV)-positive in stratum 
oriens of HIPP. NI fibers labeled with eYFP (green) and positive for relaxin-3 (white) 
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establish putative contacts (white arrowheads) with a PV-positive interneuron (red) in the 
stratum oriens of the dorsal CA1. Scale bar: 20 μm. 
I: AAV2/5-EF1α-DIO-eYFP was injected into the NI and CTB was injected into the MS 
of the same vGAT-Cre mice (n=2) to label hippocamposeptal projection neurons. 
J: Representative injection sites illustrating red CTB labeling in the MS and green eYFP 
labeling in the NI. Abbreviations: LS: lateral septum; MS: medial septum; VDB: ventral 
limb of the diagonal bands of Broca. Scale bars: 500 μm. 
K: eYFP-positive NI fibers in the HIPP (green) establish putative contacts (white 
arrowheads) with CTB-positive hippocamposeptal interneurons (red). Scale bar: 20 μm. 
L: A NI fiber labeled with brown SI-DAB establishes a synaptic contact with a CTB-
positive hippocamposeptal interneuron labeled with black DAB-Ni precipitate in the DG. 
The NI terminal reconstructed with correlated light- and electron microscopy is indicated 
with a black arrowhead. Scale bar: 10 μm. 
M: The same terminal marked in S also has a symmetrical synaptic contact (black arrow) 
on the soma (s) of a hippocamposeptal interneuron. Scale bar: 600 nm. 
N: AAV2/5-EF1α-DIO-eYFP was injected into the NI and CTB was injected into the 
subiculum of the same vGAT-Cre mice (n=2) to label hippocampo-retrohippocampal 
projection neurons. 
O: Representative injection sites illustrating red CTB labeling in the subiculum and green 
eYFP labeling in the NI. Abbreviations: PaS: parasubiculum; STr: subiculum, transition 
area. Scale bars: 500 μm. 
P: eYFP-positive NI GABAergic fibers in the HIPP (green) establish putative contacts 
(white arrowheads) with CTB-positive hippocampo-retrohippocampal interneurons (red), 
which are also positive for the type 2 muscarinic acetylcholine receptor (M2AChR, 
white). Scale bar: 20 μm. 
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Fig. S2 Projection patterns of NI and surrounding nuclei  
 
A-H: AAV2/5-EF1α-DIO-eYFP 
was injected into various areas in 
the brainstem in vGAT-Cre, 
vGluT2-Cre or GlyT2-Cre mice. 
The images illustrate 
representative coronal sections 
from the region of the different 
injection sites and from the 
hippocampus and MS, 
respectively. The centers of the 
injection sites were also identified 
and defined by their 
anteroposterior coordinates from 
Bregma. Note, that the 
characteristic vGAT-positive 
fiber labeling of the NI in these 
forebrain areas can be observed 
only in vGAT-Cre mice (A), and 
it is absent, when the AAV-eYFP 
was injected into the neighboring 
brain areas or into vGluT2-Cre or 
GlyT2-Cre mice. Scale bars 
(panel H) 500 μm for all images 
(columns of A-H). 
A: AAV2/5-EF1α-DIO-eYFP was 
injected into the nucleus incertus 
(NI) of vGAT-Cre mice (n=7). 
B: AAV2/5-EF1α-DIO-eYFP was 
injected into the median raphe 
region (MRR) of vGAT-Cre mice 
(n=2). 
C: AAV2/5-EF1α-DIO-eYFP was 
injected into the dorsal raphe 
(DR) of vGAT-Cre mice (n=2). 
D: AAV2/5-EF1α-DIO-eYFP was 
injected into the nucleus pontis 
oralis (PNO) of vGAT-Cre mice 
(n=2). 
E: AAV2/5-EF1α-DIO-eYFP was 
injected into the laterodorsal 
tegmental nucleus (LDTg) of 
vGAT-Cre mice (n=2). 
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F: AAV2/5-EF1α-DIO-eYFP was injected into the medial vestibular nucleus (MVN) of 
vGAT-Cre mice (n=2). 
G: AAV2/5-EF1α-DIO-eYFP was injected into the NI of GlyT2-Cre mice (n=2). 
H: AAV2/5-EF1α-DIO-eYFP was injected into the NI of vGluT2-Cre mice (n=2). 
I: AAV2/5-EF1α-DIO-eYFP was injected into the nucleus incertus (NI) of vGAT-Cre 
mice (n=2). We did not observe any meaningful co-localization of AAV-eYFP containing 
NI fibers and vesicular acetylcholine transporter (vAChT, only 3/320) or vGluT2 (only 
3/206) or vGluT3 (0/216) in the dorsal CA1 of the hippocampus, measured in n=2 mice 
per reaction, respectively. The apparent labeling was likely false positives. Scale bar: 20 
μm for all images per row. 
J: A representative coronal section from the pons of a vGAT-tdTomato mouse (n=2 mice 
tested) illustrates that GABAergic neurons of the NI (red) do not co-express tyrosine-
hydroxylase (TH, green) or serotonin (5-HT, blue). Scale bar: 250 μm. 
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Fig. S3 Supplementary data from in vitro recordings of NI GABAergic cells  
 
A: Experimental design of 
optogenetic in vitro intracellular 
recordings (experiment described in 
detail in Fig. 1J). 
B: Population data (n=18 cells) for 
in vitro recorded IPSC latencies 
(defined as time between stimulus 
onset and 10% of IPSC amplitude), 
10-90% rise times and 10-90% 
decay times. Data are presented (in 
ms) as follows (median [25%-75% 
quartiles]): Latency: 2.6 [2.3-3.55], 
10-90% rise time: 1.63 [1.28-1.89], 
10-90% decay-time: 11.11 [8.77-
19.02]. Black dots represent cells 
that could be both reconstructed and 
identified as OLM cells. 
C: Left panel displays averaged 
IPSCs from the O-LM cell in Fig. 
1K. Optical stimulation was 
delivered at 5 Hz (green), 10 Hz 
(yellow), 20 Hz (blue), 30 Hz (red) 
and 50 Hz (purple) to test frequency-
dependent short-term plasticity. At 
lower (5-20 Hz) frequencies, no 
short-term plasticity was evident. 
The cell displayed STD at higher 
(30-50 Hz) stimulation frequencies, 
although it is not clear whether 
ChR2 stimulation-failure at these 
higher 50 Hz frequencies may have 
contributed to an increased STD. 
Scale bars: 100 ms, 200 pA. 
Right panel: population data 
showing changes in amplitudes for 
17 cells are as follows (median 
[25%-75% quartiles]): 5 Hz: 2nd 
98.65 [83.66-109.43], 3rd 88.22 
[83.95-109.43], 4th 91.17 [81.57-
106.88], 5th 85.54 [77.57-101.30]; 
10 Hz: 2nd 99.87[76.23-118.95], 3rd 
98.25 [77.38-119.10], 4th 99.14 
[74.52-117.21], 5th 96.28 [89.98-
109.05];  
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20 Hz: 2nd 94.33 [85.83-112.23], 3rd 103.25 [83.24-124.86], 4th 91.29 [65.20-135.02], 
5th 100.83 [83.11-152.76], 30 Hz: 2nd 59.40 [46.94-96.68], 3rd 68.44 [57.20-91.52], 4th 
81.72 [58.09-114.66], 5th 85.98 [57.73-105.00] and 50 Hz: 2nd 26.48 [17.24-51.00], 3rd 
38.37 [19.77-60.98], 4th 31.68 [21.82-47.16], 5th 44.27 [18.81-71.62]. 
D: Experimental design of optogenetic in vitro intracellular recordings from NI cells. 
AAV2/5-CAG-FLEX-ArchT-GFP was injected into the NI of a vGAT-Cre mouse (n=1). 
After 6 weeks of survival, 300-μm-thick horizontal slices containing NI were cut from 
the brainstem and transferred into a dual-superfusion chamber. NI neurons were whole-
cell patch clamped in current clamp mode, and the firing activity of the neurons was 
measured, while the slices were illuminated with red light. The recorded neurons (n=4) 
were post-hoc characterized neurochemically (3 were confirmed to be relaxin-3 positive). 
E: Confocal laser scanning fluorescent image illustrates a representative GABAergic NI 
neuron expressing ArchT (green) that was recorded and filled with Biocytin (red). The 
neuron was positive for relaxin-3. Scale bar: 20 µm. 
F: In vitro red-light illumination effectively blocked action potential generation in the 
GABAergic NI neuron shown in D. Twenty (20) overlaid membrane potential traces are 
shown with 1 sec-long illumination periods (orange bar). A sample trace is provided 
(yellow). Scale bars: 1s, 20 mV. 
G: Population data illustrating action potential blockade upon illumination of NI neurons 
expressing ArchT (80 stimulation periods from 4 cells). Cumulative spike count is 
represented by bars, while individual cell spike counts are represented by lines. Yellow 
line indicates the cell shown in D-E.  
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Fig. S4 Injection sites and optic fiber localizations 
 
A: Summary of virus injection sites in every mouse used in the behavioral, in vivo or in 
vitro optogenetic experiments. The virus injection sites in the different mice participating 
in the different experiments were checked one-by-one and overlaid onto each other. 
AAV2/5-EF1a-DIO-ChR2-eYFP (ChR2) or AAV2/5-CAG-FLEX-ArchT-GFP (ArchT) 
expression is labeled with green, AAV2/5-EF1a-DIO-eYFP (CTRL) expression is labeled 
with yellow in the area of NI and adjacent structures at 3 different coronal levels (Bregma 
-5.30, -5.45 and -5.65 mm, respectively). The tips of the optic fibers positioned over the 
NI are also labeled as follows: 
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- Experiments comparing foot-shock-aligned ChR2 vs. CTRL stimulation in the NI 
(described in Fig. 6A): 
Blue rhombs: optic fibers in ChR2-expressing mice, foot-shock-aligned stimulation. 
Blue circles: optic fibers in CTRL-expressing mice, foot-shock-aligned stimulation. 
- Experiments comparing foot-shock-aligned stimulation vs. 15 seconds-shifted 
stimulations in the NI (described in Fig. 6C): 
Orange rhombs: optic fibers in ChR2-expressing mice, foot-shock-aligned stimulation. 
Orange “X”-s: optic fibers in ChR2-expressing mice, foot-shock-shifted stimulation. 
- Experiments comparing ArchT vs. CTRL inhibition (described in Fig. 6D): 
Yellow rhombs: optic fibers in ArchT-expressing mice, inhibition. 
Yellow circles: optic fibers in CTRL-expressing mice, inhibition. 
-  In vivo physiology experiments (described in Fig. 6 and Fig. S4): 
Red rhombs: optic fibers in ChR2-expressing mice, stimulation in the in vivo physiology 
experiments. 
B: Positions of the etched optic fibers at 3 different coronal levels (Bregma -2.00, -2.30 
and -2.70, respectively) in experiments comparing foot-shock-aligned ChR2 vs. CTRL 
stimulation in the HIPP (described in Fig. 6B): 
Blue multiple-pointed filled rods: etched optic fibers in ChR2-expressing mice, 
footshock-aligned stimulation. 
Blue empty rods: etched optic fibers in CTRL-expressing mice, foot-shock-aligned 
stimulation. 
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Fig. S5 In vivo hippocampal recordings during optogenetic stimulation of NI 
GABAergic cells  
 
 
 
A: Average spectral power change determined as the ratio of Welch’s periodograms 
(spectral power distribution calculated by Welch’s overlapped segment averaging 
estimator) of pyramidal LFP to the preceding 2 seconds-long non-stimulated segment 
during various stimulation protocols. Running episodes were selected during NI 
GABAergic neuron (INCERTUS, left) and control stimulations (CONTROL, right). 
TBS: theta burst stimulation, TBS1: 3 pulses at 25 Hz in bursts repeated by 5 Hz, TBS2: 
3 pulses at 50 Hz in bursts repeated by 5 Hz, TBS3: 5 pulses at 50 Hz in bursts repeated 
by 5 Hz, TBS4: 3 pulses at 50 Hz in bursts repeated by 10 Hz. 
B. Changes of summed spectral power in low theta (5-8 Hz, left) and high theta (8-12 Hz, 
right) bands. Plots show medians of data in rows corresponding to stimulation protocols 
in A (blue: NI GABAergic neuron stimulation, black: control stimulation). Significant 
effect of various stimulation protocols on high theta band power was revealed by 
Kruskal-Wallis ANOVA (𝜒2(6) = 40.9278, p < 0.001 for NI GABAergic neuron 
stimulation and 𝜒2(6) = 3.229, p = 0.7796 for control stimulation). Post-hoc test (Tukey’s 
honestly significant difference procedure) proved that 25 Hz stimulation (marked by #) 
had a significantly different effect to the other protocols. In contrast, these stimulation 
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protocols had no statistically different effect on low theta band power (Kruskal-Wallis 
ANOVA, 𝜒2(6) = 3.7744, p = 0.7072 for NI GABAergic neuron stimulation and 𝜒2(6) = 
4.0376, p = 0.6716 for control stimulation). On the right side of the plots, significant 
differences between NI GABAergic neuron and control stimulations are indicated (*: p < 
0.05, **: p < 0.01, ***: p < 0.001 two-sided Wilcoxon rank sum test). 
C. Time-resolved spectral changes during 25 Hz stimulation demonstrated by the 
continuous wavelet transform of the pyramidal layer LFP. Here, the same data are 
illustrated as in Fig. 6B, but the frequency scale is expanded to 100 Hz. Notably, besides 
theta suppression, the power of the 25-30 Hz band was increased by NI GABAergic 
neuron stimulation. However, this effect might have resulted from the interaction of 
incertus-triggered oscillations and rhythms accompanying the stimulation-induced brain 
state change (e.g. slow gamma). 
D. Ratio of Welch’s periodograms of pyramidal layer LFP during 25 Hz NI GABAergic 
cell (blue) and control stimulation (black) to the preceding 2 seconds-long non-stimulated 
segment (expressed in dB). Mean ± SEM for all stimulations when mice (n = 4) were 
running (top) or sleeping in REM state (bottom) are shown. Reduction in theta power can 
be detected by wavelet-based decomposition. Additional two peaks of increased activity 
at 25 and around 30 Hz can also be distinguished, the latter might reflect elevated slow 
gamma activity. 
E. Pyramidal spectral band power (frequency range indicated above the graphs) 
computed by Welch’s method during 25 Hz stimulation (STIM) and preceding 2 seconds-
long non-stimulated segment (PRE). Data of all individual stimulation sessions when 
mice were running (top) or sleeping in REM state (bottom) are plotted (blue: NI 
GABAergic neuron stimulation, black: control stimulation). Grey lines indicate group 
medians, significant differences between data groups are indicated (**: p < 0.01, ***: p < 
0.001, two-sided Wilcoxon signed-rank test). Suppression of higher theta band (8-12 Hz) 
activity, also shown in Fig. 6C by wavelet-based decomposition, is confirmed, and 
additionally, oscillation around 30 Hz distinct from the evoked activity at 25 Hz was 
significantly stronger during stimulation than in preceding period (power in 30 - 45 Hz 
band). 
F-I. Depth profile of hippocampal electrical activity. On the left side of every image, 
current source density maps of averaged LFP from a mouse during NI GABAergic 
neuron stimulation (STIM) and preceding 2 seconds-long non-stimulated segment (PRE) 
are shown. Schematic principal neurons of CA1 and dentate gyrus were arranged to the 
corresponding recording sites of the silicon probe. On the right side of every image, 
averaged difference of maximal sinks (STIM-PRE) during all 25 Hz NI GABAergic 
neuron (blue) and control (black) stimulations in n = 4 mice are displayed as group 
medians and 25th - 75th percentile range. Significant difference between NI GABAergic 
neuron and control stimulations are indicated (*: p < 0.05, **: p < 0.01, ***: p < 0.001, 
two-sided Wilcoxon rank sum test). Current source density maps are averaged by the 
individual stimulation pulses repeated at 25 Hz (F, G), or by the peaks of pyramidal layer 
theta cycles (H, I) in running (F, H) or REM sleep episodes (G, I). White dashed lines on 
the maps indicate the pulse onset (F,G), or the peak of the theta cycle (H,I). 
Abbreviations: pyr: stratum pyramidale; rad: stratum radiatum; l-m: stratum lacunosum-
moleculare; mol: stratum moleculare; hil: hilus. 
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Fig. S6 Supplementary control data for contextual fear conditioning experiments 
 
 
 
A: Illustration of the experimental design that was used as an additional control for 
experiments described in Fig. 6A. ChR2- or CTRL-mice were placed into a multisensory 
context (environment ”A”) to receive foot-shocks and foot-shock-aligned optogenetic 
stimulation of NI. On the 6th day, freezing behavior in environment ”A” was analyzed, 
followed by assessment of anxiety levels in the elevated plus maze, 1 hour later. After 5 
days of extensive handling, on the 13th day, mice were placed into a completely new 
context (environment ”B”). Here, they displayed normal exploratory behavior without 
freezing, indicating that their previously established fear memories were specific for 
environment ”A”. In environment ”B” they received 4 foot-shocks (2 mA, 2 s) with a 30 
second inter-shock interval without laser stimulation. On day 14, mice were placed back 
to environment ”B” to analyze their freezing behavior. 
B: ChR2 mice spent significantly more time freezing in environment ”B” than in 
environment ”A”, indicating that NI successfully inhibited contextual fear memory 
formation in environment ”A”. Population data for freezing (in % of total time) are as 
follows (median [25%-75% quartiles]): ChR2 in environment ”A”: 1.22 [0.00-2.45], 
ChR2 in environment ”B”: 6.34 [2.22-12.85]  (*: p=0.018, Wilcoxon signed-rank test). 
Freezing levels of ChR2 and CTRL mice were not different in environment ”B”, 
indicating that both groups of mice were capable of forming contextual fear memories. 
Population data for freezing (in % of total time) are as follows (median [25%-75% 
quartiles]): ChR2 in environment ”B”: 6.34 [2.22-12.85], CTRL in environment ”B”: 
12.12 [5.78-16.80] (n.s: non-significant, p=0.417, Mann-Whitney U-test). Graph shows 
individual data (dots) and medians (lines). 
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Table S1. Primary antibodies and retrograde tracers 
Antigen Host Dilution Source 
Catalog 
number 
     
Calbindin Rabbit 1:2000 Kind gift from K. Baimbridge - 
choline 
acetyltransferase 
(ChAT) 
Mouse 1:1000 Kind gift from C. Cozzari - 
Choleratoxin B 
subunit 
Goat 1:20000 List Biologicals #703 
Choleratoxin B 
subunit 
Mouse 1:2000 Abcam ab1003 
eGFP Chicken 1:1000 Abcam ab13970 
eGFP Chicken 1:2000 ThermoFisher Scientific A10262 
eGFP Rabbit 1:1000 ThermoFisher Scientific A11122 
FluoroGold Rabbit 1:500 Chemicon AB153-i 
GABA-A-g2 Rabbit 1:1000 Synaptic Systems 224 003 
Gephyrin Mouse 1:100 Synaptic Systems 147 021 
Gephyrin Rabbit 1:300-1:2000 Synaptic Systems 147 008 
M2 Rat 1:500 Chemicon MAB367 
mCherry Rabbit 1:5000 BioVision 5993-100 
mGluR1a Rabbit 1:2000 ImmunoStar 24426 
Parvalbumin Guinea pig 1:10000 Synaptic Systems 195 004 
Parvalbumin Rabbit 1:2000 Kind gift from K. Baimbridge - 
Relaxin-3 Mouse 1:20-1:1000 Provided by A.L. Gundlach - 
RFP Rat 1:2000-
1:5000 
Chromotek 5F8 
Serotonin Rabbit 1:10000 ImmunoStar 20080 
Somatostatin Rabbit 1:1000 Acris/OriGene AP33464SU-N 
Somatostatin Rat 1:300-1:1000 Chemicon MAB354 
tyrosine hydroxylase 
(TH) 
Mouse 1:2000 ImmunoStar 22941 
vesic. acetylcholine 
transporter (vAchT) 
Goat 1:10000 ImmunoStar 24286 
vesicular GABA 
transporter (vGAT) 
Guinea pig 1:2000 Synaptic Systems 131 004 
vesicular glutamate 
transporter type 2 
(vGluT2) 
Guinea pig 1:2000 Synaptic Systems 135 404 
(vGluT3) Rabbit 1:500 Synaptic Systems 135 203 
Choleratoxin B 
subunit 
 0,5% List Biologicals  #104 
FluoroGold  2% FluoroChrome Inc. - 
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Table S2. Characterization of the primary antibodies and retrograde tracers used. 
 
Antigen Host Specificity Characterized in 
    
Calbindin Rabbit The antibody recognizes one major broad band of 
the expected molecular weight (28 kDa) on 
western blots from rat cerebellum samples and 
immunostaining was abolished by preadsorption 
with the immunogen. 
[1] 
choline 
acetyltransfera
se (ChAT) 
Mouse Staining is typical for cholinergic cells; complete 
overlap of staining with eYFP-positive cells in ChAT-
iRES-Cre mice injected with AAV-EF1a-DIO-eYFP. 
[2,3] 
Choleratoxin B 
subunit 
Goat No staining in non-injected mice. [4] 
Choleratoxin B 
subunit 
Mouse No staining in non-injected mice. [5] 
eGFP (Abcam) Chicken No staining in mice not injected with eGFP-
expressing virus. 
Information of the 
distributor 
eGFP (Thermo 
Fisher Sci.) 
Chicken No staining in mice not injected with eGFP-
expressing virus. 
Information of the 
distributor 
eGFP Rabbit No staining in mice not injected with eGFP-
expressing virus. 
Information of the 
distributor 
FluoroGold Rabbit No staining in non-injected mice. [6] 
GABA-A-γ2 Rabbit No staining in GABA-A-γ2 floxed mice in areas 
injected with AAV-Cre (conditional knockout); 
extracellular epitope. 
[7] 
Gephyrin Mouse KO verified. Information of the 
distributor 
Gephyrin Rabbit KO verified. Information of the 
distributor 
M2 Rat KO verified. [8] 
mCherry Rabbit No staining in mice not injected with mCherry-
expressing virus. 
Information of the 
distributor 
mGluR1a Rabbit Several antibodies for different epitopes gave the 
same labeling pattern. 
[9] 
Parvalbumin Guinea 
pig 
Labels the same cell populations in the brain as 
other antibodies to parvalbumin. 
Information of the 
distributor, [10] 
Parvalbumin Rabbit Labels the same cell populations in the brain as 
other antibodies to parvalbumin. 
[11,12] 
Relaxin-3 Mouse KO verified. [13] 
RFP Rat No staining in mice not injected with mCherry-
expressing virus. 
Information of the 
distributor 
Serotonin Rabbit Staining is typical for serotonergic neurons, 
complete overlap with TpH-staining. 
[14,15] 
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Somatostatin Rabbit Labels the same neuron populations in the brain as 
other antibodies to somatostatin. 
[16] 
Somatostatin Rat Labels the same neuron populations in the brain as 
other antibodies to somatostatin. 
[17] 
TH Mouse Staining is typical for TH-positive neurons. [18] 
vesicular 
acetylcholine 
transporter 
(vAchT) 
Goat Complete overlap with ChAT staining. [3] 
vesicular GABA 
transporter 
(vGAT) 
Guinea 
pig 
KO verified. Information of the 
distributor 
vesicular 
glutamate 
transporter 
type 2 (vGluT2) 
Guinea 
pig 
The antibody recognizes one major broad band of 
the expected molecular weight (65 kDa) on 
western blots of a synaptic vesicle fraction of rat 
brain and immunostaining was abolished by 
preadsorption with the immunogen. 
Information of the 
distributor, [19] 
vesicular 
glutamate 
transporter 
type 3 (vGluT3) 
Rabbit KO verified. Information of the 
distributor 
Choleratoxin B 
subunit 
 Retrograde tracer. [20] 
FluoroGold  Retrograde tracer. [20] 
 
Footnote: [1] A.M.J. Buchan, K.G. Baimbridge, Peptides 9 (1988) 333–338. [2] A. Chédotal et al. Brain 
Res. 646 (1994) 181–193. [3] V.T. Takács et al., Nat. Commun. 9 (2018). [4] P.J.W.C. Dederen et al., 
Histochem. J. 26 (1994) 856–862. [5] K.T. Hamorsky et al. PLoS Negl. Trop. Dis. 7 (2013). [6] C. Varga et 
al. J. Neurosci. 22 (2002) 6186–6194. [7] Z. Rovo et al.  J. Neurosci. 34 (2014) 7137–7147. [8] K.A. 
Kohlmeier et al. J. Neurophysiol. 108 (2012) 2751–2766. [9] R.G.E. Notenboom et al., Brain 129 (2006) 
96–107. [10] L. Massi et al., J. Neurosci. 32 (2012) 16496–16502. [11] F. Condé et al. J. Comp. Neurol. 
341 (1994) 95–116. [12] F. Mascagni et al. Neuroscience 158 (2009) 1541–1550. [13] S. Ma et al. J. 
Physiol. 591 (2013) 3981–4001. [14] S.R. Fox, E.S. Deneris, J. Neurosci. 32 (2012) 7832–42. [15] S. KE et 
al., Brain Struct. Funct. 222 (2016) 287–299. [16] F. Antonucci et al. J. Neurosci. 32 (2012) 1989–2001. 
[17] Y. Kubota et al. Cereb. Cortex 21 (2011) 1803–1817. [18] M. Chermenina et al. Parkinsons. Dis. 1 
(2015). [19] J. Broms et al.  J Comp Neurol 523 (2016) 359–380. [20] J.L. Lanciego et al.  J. Chem. 
Neuroanat. 42 (2011) 157–183. 
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Table S3. Secondary antibodies. 
 
Raised in 
(species) 
Raised 
against 
(species) 
Conjugated 
with 
Dilution Source Catalog 
number 
      
Chicken Rat Alexa 647 1:500 ThermoFisher Scientific A21472 
Donkey Rabbit Alexa 647 1:500 Jackson Immunoresearch 711-605-152 
Donkey Mouse Alexa 647 1:500 Jackson Immunoresearch 715-605-151 
Donkey Guinea pig Alexa 647 1:500 Jackson Immunoresearch 706-605-148 
Goat Chicken Alexa 488 1:1000 ThermoFisher Scientific A11039 
Donkey Chicken Alexa 488 1:300 Jackson Immunoresearch 703-545-155 
Donkey Goat Alexa 488 1:500 ThermoFisher Scientific A11055 
Donkey Rabbit Alexa 488 1:1000 ThermoFisher Scientific A21206 
Donkey Mouse Alexa 488 1:500 ThermoFisher Scientific A21202 
Goat Guinea pig Alexa 488 1:500 ThermoFisher Scientific A11073 
Donkey Goat Alexa 594 1:500 ThermoFisher Scientific A11058 
Donkey Guinea pig Cy3 1:500 Jackson Immunoresearch 706-166-148 
Donkey Rabbit Alexa 594 1:500 ThermoFisher Scientific A21207 
Donkey Rat Alexa 594 1:500 ThermoFisher Scientific A21209 
Donkey Guinea pig Alexa 594 1:500 Jackson Immunoresearch 706-585-148 
Donkey Mouse Alexa 594 1:500 ThermoFisher Scientific A21203 
Goat Chicken biotinylated 1:200 Vector Laboratories BA-9010 
Goat Rat biotinylated 1:1000 Jackson Immunoresearch 112-066-062 
Donkey Mouse biotinylated 1:1000 Jackson Immunoresearch 715-066-151 
Donkey Rabbit biotinylated 1:1000 Jackson Immunoresearch 711-065-152 
Goat Rat Horseradish 
peroxidase 
(ImmPress) 
1:3 Vector Laboratories MP-7444 
Horse Mouse Horseradish 
peroxidase 
(ImmPress) 
1:3 Vector Laboratories MP-7402 
Goat Mouse 0.8 nm gold 1:50 Aurion 800 022 
Goat Rabbit 1.4 nm gold 1:100 Nanoprobes #2004 
 streptavidin Alexa 594 1:500 ThermoFisher Scientific S11227 
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Table S4. Primary and secondary antibody combinations used in 
immunofluorescence experiments. 
Mouse strain Primary antibodies used Secondary antibodies used  
C57Bl/6 WT rabbit-anti-FluoroGold Alexa 488-conjugated donkey-anti-rabbit 
goat-anti-Choleratoxin B Alexa 594-conjugated donkey-anti-goat 
C57Bl/6 WT rabbit-anti-FluoroGold Alexa 488-conjugated donkey-anti-rabbit 
goat-anti-Choleratoxin B Alexa 594-conjugated donkey-anti-goat 
mouse-anti-Relaxin-3 Alexa 647-conjugated donkey-anti-mouse 
C57Bl/6 WT guinea pig-anti-Parvalbumin Alexa 488-conjugated goat-anti-guinea pig 
mouse-anti-Relaxin-3 Alexa 594-conjugated donkey-anti-mouse 
rabbit-anti-Gephyrin Alexa 647-conjugated donkey-anti-rabbit 
ChAT-iRES-Cre;  
vGluT2-iRES-Cre 
chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated goat-anti-chicken 
mouse-anti-Relaxin-3 Alexa 594-conjugated donkey-anti-mouse 
rabbit-anti-Gephyrin Alexa 647-conjugated donkey-anti-rabbit 
SOM-iRES-Cre chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated goat-anti-chicken 
mouse-anti-Relaxin-3 Alexa 594-conjugated donkey-anti-mouse 
rabbit-anti-Gephyrin Alexa 647-conjugated donkey-anti-rabbit 
vGAT-Cre chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated goat-anti-chicken 
rat-anti-somatostatin Alexa 594-conjugated donkey-anti-rat 
rabbit-anti-mGluR1alpha Alexa 647-conjugated donkey-anti-rabbit 
vGAT-Cre chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated goat-anti-chicken 
mouse-anti-Relaxin-3 Alexa 594-conjugated donkey-anti-mouse 
rabbit-anti-parvalbumin Alexa 647-conjugated donkey-anti-rabbit 
vGAT-iRES-Cre,  
GlyT2-iRES-Cre, vGluT2-
iRES-Cre 
chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated goat-anti-chicken 
vGAT-tdTomato mouse-anti-tyrosine hydroxylase Alexa 488-conjugated donkey-anti-mouse 
rabbit-anti-serotonin Alexa 647-conjugated donkey-anti-rabbit 
vGAT-Cre rabbit-anti-eGFP Alexa 488-conjugated donkey-anti-rabbit 
vGAT-Cre chicken-anti-eGFP (Abcam) Alexa 488-conjugated donkey-anti-chicken 
vGAT-Cre rat-anti-RFP Alexa 594-conjugated donkey-anti-rat 
vGAT-Cre chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated goat-anti-chicken 
rat-anti-RFP Alexa 594-conjugated donkey-anti-rat 
vGAT-Cre mouse-anti-ChAT Alexa 488-conjugated donkey-anti-mouse 
rabbit-anti-mCherry Alexa 594-conjugated donkey-anti-rabbit 
vGAT-Cre guinea pig-anti-Parvalbumin Alexa 488-conjugated goat-anti-guinea pig 
rat-anti-RFP Alexa 594-conjugated donkey-anti-rat 
rabbit-anti-Calbindin Alexa 647-conjugated donkey-anti-rabbit 
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vGAT-Cre rat-anti-RFP Alexa 594-conjugated donkey-anti-rat 
guinea pig-anti-vGluT2 Alexa 647-conjugated donkey-anti-guinea pig 
vGAT-Cre goat-anti-vAchT Alexa 488-conjugated donkey-anti-goat 
rat-anti-RFP Alexa 594-conjugated donkey-anti-rat 
vGAT-Cre rat-anti-RFP Alexa 594-conjugated donkey-anti-rat 
rabbit-anti-vGluT3 Alexa 647-conjugated donkey-anti-rabbit 
vGAT-Cre chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated goat-anti-chicken 
mouse-anti-Relaxin-3 Alexa 594-conjugated donkey-anti-mouse 
guinea pig-anti-vGAT Alexa 647-conjugated donkey-anti-guinea pig 
vGAT-Cre chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated goat-anti-chicken 
guinea pig-anti-vGAT Cy3-conjugated donkey-anti-guinea pig 
mouse-anti-Relaxin-3 Alexa 647-conjugated donkey-anti-mouse 
vGAT-Cre rabbit-anti-eGFP Alexa 488-conjugated donkey-anti-rabbit 
goat-anti-Choleratoxin B Alexa 594-conjugated donkey-anti-goat 
vGAT-Cre rabbit-anti-eGFP Alexa 488-conjugated donkey-anti-rabbit 
goat-anti-Choleratoxin B Alexa 594-conjugated donkey-anti-goat 
rat-anti-M2 receptor Alexa 647-conjugated chicken-anti-rat 
vGAT-Cre chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated donkey-anti-rabbit 
Alexa 594-conjugated Streptavidin Alexa 594-conjugated Streptavidin 
rat-anti-somatostatin Alexa 647-conjugated donkey-anti-rat 
vGAT-Cre chicken-anti-eGFP (ThermoFisher) Alexa 488-conjugated donkey-anti-rabbit 
Alexa 594-conjugated Streptavidin Alexa 594-conjugated Streptavidin 
rabbit-anti-somatostatin Alexa 647-conjugated donkey-anti-rabbit 
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Table S5. Primary and secondary antibody combinations used in the double 
immunogold-immunoperoxidase and in the double immunoperoxidase experiments. 
 
C57Bl/6 WT 
mouse-anti-Relaxin-3 biotinylated donkey-anti-mouse 
rabbit-anti-Gephyrin 1.4 nm gold-conjugated goat-anti-rabbit 
C57Bl/6 WT 
mouse-anti-Relaxin-3 biotinylated donkey-anti-mouse 
rabbit-anti-GABA-A-g2 1.4 nm gold-conjugated goat-anti-rabbit 
vGAT-Cre 
rabbit-anti-mCherry biotinylated donkey-anti-rabbit 
mouse-anti-Gephyrin 0.8 nm gold-conjugated goat-anti-mouse 
vGAT-Cre 
rat-anti-RFP biotinylated goat-anti-rat 
rabbit-anti-GABA-A-g2 1.4 nm gold-conjugated goat-anti-rabbit 
vGAT-tdTomato 
chicken-anti-eGFP (ThermoFisher) biotinylated goat-anti-chicken 
rat-anti-RFP ImmPress goat-anti-rat 
vGAT-Cre 
chicken-anti-eGFP (ThermoFisher) biotinylated goat-anti-chicken 
rat-anti-somatostatin ImmPress goat-anti-rat 
vGAT-Cre 
chicken-anti-eGFP (ThermoFisher) biotinylated goat-anti-chicken 
mouse-anti-Choleratoxin B ImmPress horse-anti-mouse 
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Table S6. Quantification of monosynaptically-labeled neurons with rabies virus in 
the different brain areas projecting to GABAergic NI neurons. 
 
Brain Area/Nucleus 
M
ed
ia
n
 %
 Estimation of cell numbers 
per brain area 
Behavioral relevance References for 
behavioral relevance 
Mouse 
1 
Mouse 
2 
Mouse 
3 
 
 
Prefrontal cortex 2,6% 174 654 138 fear behavior, reward, aversion [1,2] 
Cingulate cortex 1,4% 210 156 72 negative outcome of choice, aversion [3] 
Secondary motor cortex 1,3% 102 198 72 adaptive choice behavior, linking sensory cues 
to motor actions 
[4] 
Medial septum + Ventral 
limb of the diagonal band 
of Broca 
1,3% 150 192 102 theta generation, episodic memory, sleep-
wake cycles, motor control 
[5–7] 
Horizontal limb of the 
diagonal band of Broca + 
Substantia Innominata + 
nucleus basalis 
1,3% 156 138 102 unexpected events with emotional valence [8] 
Lateral preoptic area 1,2% 54 186 162 aversion, reward system, CRH input into NI [9] 
Lateral habenula 4,1% 162 636 342 aversion, reward system [9–11] 
Zona incerta 2,3% 198 354 132 fear, freezing, attention, motor control [12–14] 
Lateral hypothalamus 4,3% 228 678 234 feeding-related reward behavior [15–17] 
Posterior hypothalamus 2,3% 276 276 138 theta rhythm, spatial memory [18,19] 
Mammillary body/ 
supramammillary 
5,0% 600 960 60 motor control (head direction), memory 
formation, REM sleep 
[19–22] 
Periaqueductal grey 3,8% 696 390 198 freezing behavior [23] 
Ventral tegmental area 1,7% 204 66 96 reward processing, aversion [2] 
Mesencephalic reticular 
formation 
1,5% 306 240 6 movement initiation [24] 
Dorsal raphe 3,8% 516 276 198 reward-related behavior, sleep-wake cycles [25,26] 
Median raphe 20,2% 2022 3156 1224 fear memory consolidation, anxiety and fear [27,28] 
Nucleus pontis oralis 6,3% 414 984 600 REM sleep, theta generation [29,30] 
Isthmic reticular 
formation 
1,3% 42 210 108 movement initiation [24] 
Anterior/ventral 
tegmental nucleus 
(Gudden) 
2,3% 300 102 120 REM sleep, theta generation, memory, motor 
control (head direction) 
[31–34] 
Laterodorsal tegmental 
nucleus 
8,0% 954 N/A N/A reward processing (cocaine addiction) [2,35] 
Dorsomedial tegmental 
area 
1,7% 444 258 78 REM sleep [36] 
Nucleus pontis caudalis 3,9% 462 636 114 motor control (movement initiation, acoustic 
startle, eye movement), REM sleep 
[29,37,38] 
Medial parabrachial 
nucleus 
1,4% 168 42 84 taste perception (flavor avoidance), REM-
NREM sleep-stage transitions 
[39,40] 
Nucleus prepositus 1,1% 312 168 12 motor control (head direction) [41,42] 
Gigantocellular nucleus 4,2% 504 678 102 sleep-wake cycles, motor control (REM atonia, 
emotional movement) 
[40,43,44] 
TOTAL 88,3% 11982 15630 5238  
 
 
Footnote: [1] R.R. Rozeske et al., Brain Behav. 14 (2015) 22–36. [2] S. Lammel et al., Nature 491 (2012) 212–217. [3] T. Kawai et al., Neuron 88 
(2015) 792–804. [4] F. Barthas, A.C. Kwan, Trends Neurosci. 40 (2017) 181–193. [5] M. Vandecasteele et al., Proc. Natl. Acad. Sci. 111 (2014) 
13535–13540. [6] R. Boyce et al., Science (80-. ). 352 (2016) 812. [7] F. Fuhrmann et al., Neuron 86 (2015) 1253–1264. [8] B. Hangya et al., Cell 162 
(2015) 1155–1168. [9] D.J. Barker et al., Cell Rep. 21 (2017) 1757–1769. [10] A.M. Stamatakis, G.D. Stuber, Nat. Neurosci. 15 (2012) 1105–1107. 
[11] T.C. Jhou et al., Neuron 61 (2009) 786–800. [12] X.L. Chou et al., Nat. Commun. 9 (2018) 1–12. [13] S. Chometton et al., Brain Struct. Funct. 
222 (2017) 2507–2525. [14] G.D.R. Watson et al., J. Neurosci. 35 (2015) 9463–9476. [15] J.-J. Liu et al., J. Neurosci. 37 (2017) 11854–11866. [16] M. 
Fattahi et al., Addict. Biol. (2018). [17] A.G. Choudhary et al., Brain Struct. Funct. 223 (2018) 1313–1328. [18] R. Bocian et al., Hippocampus 26 
(2016) 1354–1369. [19] B.E. Gutiérrez-Guzmán et al., Eur. J. Pharmacol. 682 (2012) 99–109. [20] C.M. Dillingham et al., Neurosci. Biobehav. Rev. 54 
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(2015) 108–119. [21] S.D. Vann, J.P. Aggleton, Nat. Rev. Neurosci. 5 (2004) 35–44. [22] P.H. Luppi et al., Curr. Opin. Neurobiol. 44 (2017) 59–64. 
[23] P. Tovote et al., Nature, Press 534 (2016) 206–212. [24] T.K. Roseberry et al., Cell 164 (2016) 526–537. 
[25] M. Luo et al., Learn Mem 22 (2015) 452–460. [26] J.M. Monti, Sleep Med. Rev. 15 (2011) 269–281. [27] D. V Wang et al., Nat. Neurosci. 18 
(2015) 728–35. [28] T.G. Andrade et al., J. Psychopharmacol. 27 (2013) 1107–15. [29] L.D. Sanford et al., J. Neurophysiol. 90 (2003) 938–945. [30] 
R.P. Vertes, B. Kocsis, Neuroscience 81 (1997) 893–926. [31] P. Torterolo et al., Brain Res. 944 (2002) 184–189. [32] M.H. Bassant et al., 
Hippocampus 11 (2001) 809–813. [33] P.E. Sharp et al., Behav. Neurosci. 115 (2001) 571–588. [34] S.D. Vann, Brain 132 (2009) 2372–2384. 
[35] K. Kaneda, Eur. J. Neurosci. (2018) 0–1. [36] S. Valencia Garcia et al., Brain Struct. Funct. 223 (2018) 2733–2751. [38] J. Márquez-Ruiz, M. 
Escudero, Sleep 33 (2010) 1517–1527. [39] M.L. De La Torre, Á. Agüero, Exp. Brain Res. 194 (2009) 207–218. [40] Y. Hayashi et al., Science (80). 
350 (2015) 957–962. [41] W.N. Butler et al., Curr. Biol. 27 (2017) 1259–1267. [42] W.N. Butler, J.S. Taube, J. Neurosci. 35 (2015) 2547–2558. [43] 
E.M. Martin et al., J. Comp. Neurol. 519 (2011) 2574–2593. [44] Y.-Y. Lai et al., J. Neurophysiol. 104 (2010) 2024–2033. 
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Table S7. Immunochemical characterization of basal forebrain neurons (medial 
septum, vertical and horizontal limbs of the diagonal bands of Broca and substantia 
innominata pooled) monosynaptically projecting onto GABAergic NI neurons. 
 
 Number Percentage to total 
number of cells labeled 
Total counted basal forebrain neurons for analyzing ChAT-positivity 35 2,86% 
ChAT-positive neurons (n=1 mouse) 1 
 
Total counted basal forebrain neurons for analyzing PV-positivity 97 18,56% 
PV-positive neurons (n=3 mice) 18 
 
Total counted basal forebrain neurons for analyzing CB-positivity 97 5,15% 
CB-positive neurons (n=3 mice) 5 
 
 
 
 
